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Volumetric muscle loss overwhelms skeletal muscle’s ordinarily capable regenerative machinery, 
resulting in fibrosis and severe functional deficits which have defied clinical repair 
strategies. My work spans the design and preclinical evaluation of implants intended to drive 
the cell community of injured muscle toward a regenerative state, as well as the development 
of an understanding of the molecular responses of this cell community to biomaterial interventions. 
I demonstrate a new class of biomaterial by leveraging the productive capacity of 
sacrificial hollow fiber membrane cell culture; I show specifically that unique threads of 
whole extracellular matrix can be isolated by solvent degradation of cultured hollow fiber 
systems and that this matrix exhibits composition and structure appropriate for wound healing 
applications. I additionally demonstrate the application of an emerging pore characterization 
technique and contribute a new open source software for evaluation of mesoporous pore 
diameter distribution and surface area, key properties governing the performance of sacrificial cell 
culture materials. Toward a better understanding of the biomolecular systems mediating implant 
efficacy, I demonstrate the first transcriptomic investigation of a specific promising 
combinatorial cell-scaffold implant in a rat model of volumetric muscle loss, showing an expedited 
recovery of muscle contractile force concurrent with a coordinated upregulation of 
peripheral neuroregenerative signaling. Together, these findings establish a new scalable approach 
for the production of biomimetic implant materials in vitro as well as molecular targets informing 
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A. The Cell Community of Skeletal Muscle in Health and Injury  
 
 Skeletal muscle is a complex tissue which functions to enable locomotion through the 
transmission of force about joints. It represents the most massive constituent of the human body 
by mass, representing up to ~40% of adult male body mass1,2 and therefore is a major contributing 
factor in resting energy expenditure3 despite exhibiting a specific metabolic rate an order of 
magnitude lower than that of the major organs.4 This tissue manifests largely as bilateral pairs of 
muscles comprising a specialized community of cells containing the molecular machinery which 
transduces action potentials into muscle contractions, producing forces which are carried across 
musculotendinous junctions to bone, enabling movement. 
Much of the fundamental anatomy of skeletal muscle was explored in depth in the 19th 
century, with a remarkable number of early histological studies exploring the complex anatomy 
and physiology of the muscle-nerve interface across different pathologies.5 Muscle is principally 
composed of cylindrical cells (myofibers) approximately 100 µm in diameter with a length of up 
to several centimeters and organized into bundles (fascicles) separated into a honeycomb structure 
by a distinct connective tissue (perimysium) comprising thick and thin layers composed primarily 
of the fibrillar collagens I, III, and V,6 though the precise amount and composition of both the 
perimysium and the finer matrix encasing individual myofibers (endomysium) can vary 
considerably between muscles of different function and age.7 The perimysium further hosts nerve 
fibers and arterioles branching into capillaries supplying the endomysium as well as corresponding 
venules.  Muscle contraction is enabled by the action of complex protein superstructures termed 




contain the largest human protein, the up-to 3000 kDa Titin, estimated to represent 8.5% of total 
myofibril protein.8,9 Within each sarcomere reside “thick” and “thin” myofibril filaments 
composed principally of myosin and actin, respectively; myosin filaments are anchored to the 
center of the sarcomere (the “M-line”), while actin filaments are anchored to the z-discs. Muscle 
contraction is produced when these actin filaments are made to overlap myosin; action potentials 
stimulate myofibers to release Ca2+ from the sarcoplasmic reticulum into the sarcoplasm, where it 
binds a troponin-tropomyosin complex to uncover a binding site for myosin on actin. 
Conformational changes induced by binding of ATP to myosin and subsequent dissociation of Pi 
and ADP lead to a strong association of its actin-binding domain with actin, forming the canonical 
“cross-bridge”10 which pulls actin filaments, bringing their associated z-discs closer together. An 
additional ATP-myosin binding event results in dissociation of the myosin-actin cross-bridge, 
concluding the cycle.  While myofibers represent the critical contractile cell of muscle, skeletal 
muscle is supported by a broader community of resident and injury-responsive infiltrating cells. 
The innate heterogeneity of these cell populations has presented challenges in terms of the 
identification of reliable molecular markers. However, improvements in methods have led to 
emerging evidence and interest in the roles of these cells in normal muscle function, injury, and 
regeneration.  
 The cells of the skeletal muscle community can be broadly divided based on their capability 
for myogenic differentiation; In 1961, analysis of frog muscle electromicrographs by Alexander 
Mauro11 indicated the presence of a previously unknown cell type residing between the cell 
membrane (sarcolemma) of myofibers and the basal lamina of the basement membrane. These 
satellite cells –so called for their adjacency to myofibers- are now known to be requisite for the 




PAX7, a transcription factor which in these cells has been shown to regulate the transcription of 
hundreds of genes through a combination of paired domain and homeobox domain DNA binding.14 
Upon mild muscle injury, these cells are “activated,” having been observed to undergo a phase of 
proliferation concurrent with coexpression of PAX7, MYF5, and ultimately MYOD. MYF 5 and 
MYOD appear to bind identical loci, with MYF5 promoting histone acetylation while MYOD 
participates in histone acetylation and the recruitment of RNA polymerase II, initiating 
transcription of the myogenic program.15  Through a variety of mechanisms, mild muscle 
damage incurred by exercise or trauma facilitates the action of several signals which serve to 
activate satellite cells, including HGF, MGF, and FGFs, with Wnt and Notch signaling also having 
prominent roles.16 In particular, myofibers contain mechanosensitive Ca2+ import channels which 
are thought to respond to stretching by importing Ca2+ into the cytoplasm of the myofiber 
(sarcoplasm), where it binds calmodulin.17 Calmodulin is bound by nitric oxide synthase (NOS), 
eliciting electron transfer from NADPH to an FAD domain and finally the heme prosthetic group 
of NOS, after which the enzyme catalyzes the conversion of arginine to citrulline and gaseous 
NO.18 NO freely diffuses across the sarcolemma into the extracellular matrix, where it may 
participate in conversion of the zymogenic form of the matrix metalloproteinase (MMP) MMP-2 
to its active form through a nitrosylation mechanism known to occur in MMP-9 activation.19-21 
MMP-2 participates in proteolytic cleavage of ECM, liberating HGF bound to collagen and other 
ECM constituents.22-25 The binding of HGF with its receptor c-Met and resulting activation of the 
c-Met signaling pathway26 is a key early step in satellite cell activation, and the intramuscular 
injection of exogenous HGF has been shown to activate quiescent satellite cells in vivo27, though 
there also appears to be a negative feedback effect of high concentrations of HGF (>50 ng/mL) on 




of proliferation, Pax7+/Myf5- satellite stem cells can produce two daughter cells whose fates are 
determined by their orientation relative to the myofiber and basal lamina; in this asymmetric 
division the myofiber-facing daughter cell upregulates Myf5 expression and becomes committed 
toward a myogenic fate (a satellite myogenic cell) while the daughter cell in contact with the basal 
lamina remains Myf5-, which together with the planar symmetric division of Pax7+/Myf5- cells 
serves to replenish the pool of quiescent satellite cells.29,30Pax7+/Myf5+ cells also undergo planar 
division in which case both daughters are committed to myogenesis.31 
 Following activation, satellite cells –at this point often classified as myoblasts- exhibit a 
remarkable ability to migrate to sites of injury across relatively large distances both along32 and 
between myofibers, with some evidence indicating that these cells can migrate between adjacent 
muscles.33,34 A precise mechanism of myoblast migration has yet to be described, but many of the 
relevant molecular participants have been identified. Myoblasts express receptors for a number of 
chemokines released by damaged myofibers and other cells which appear to promote myoblast 
migration in a manner that is independent of their effects on leukocyte recruitment.35-37 Syndecan-
4, a well described transmembrane receptor for ECM components, participates in signal 
transduction governing cell proliferation and motility38, and has been directly implicated in 
regulating the migration of satellite cells through RhoA39, with inhibition of this signaling also 
shown to impair focal adhesion formation40. The activity of matrix metalloproteinases –especially 
MMP-9- is necessary for normal myoblast migration across the ECM and basal lamina41,42, and 
given the promotion of MMP activity by ECM-resident growth factors such as bFGF43 and HGF44, 
 the liberation of additional ECM-bound factors during migration could play an important role in 
the guidance of myoblasts to injuries. The physical properties and spatial constraints of the ECM 




ECM digestion and turnover, including the diffuse release, cell surface localization, or lysosomal 
localization of proteases.45 Upon arriving at a site of injury, myoblasts undergo a program of 
differentiation by which they can fuse with each other to form immature myocytes termed 
myotubes which themselves fuse to the sealed ends of existing damaged myofibers form a nascent 
regenerating myofiber.46 Myogenin is a key myogenic regulatory factor (MRF) which in 1989 was 
shown to direct myoblasts toward differentiation and fusion.47  
Intriguingly, while satellite cells are generally accepted as the principal contributors to 
myogenesis, some nonclassical muscle interstitial cells are capable of myogenic differentiation 
under certain conditions. Mitchell et al identified a subset of PW1+/Pax7- interstitial cells 
(myoPICs) participating in myotube formation in vitro and in vivo that were shown to be of a 
separate embryonic lineage from satellite cells (PW1+/Pax7+) by their absence of positive 
recombinant β-galactosidase staining in Pax3Cre × RosalacZ mice, though they do express both 
Pax3 and Pax7 upon commitment to a myogenic program.48 PICs appear to exhibit potential for 
skeletal muscle, smooth muscle, and fibro-adipogenic differentiation; further, a subset of PICs 
expressing PDGFRα exhibits an adipocyte-like pattern of gene expression in vitro and may have 
some relation to populations of fibro-adipogenic progenitors (FAPs) identified in skeletal 
muscle.49 Recent evidence demonstrating a responsiveness of PICs to satellite cell depletion 
and an increased PIC population during rescue of myofiber atrophy by pharmacological 
inhibition of AcvR2B suggests physiological roles for PICs in muscle regeneration warranting 
further study.50 
Rouget cells, a variety of contractile cell encircling capillary endothelial cells first 
described by Eberth51 and Rouget52-54 and recoined as “pericyten” (pericytes) by Zimmerman55, 




evidence has emerged demonstrating the multipotent differentiability of these cells –as well as 
their mesoangioblast counterparts in the large vessels- toward osteogenic, chondrogenic, 
adipogenic, and myogenic lineages56; in fact, Crisan et al demonstrated that pericytes express 
mesenchymal stem cell (MSC) markers and display MSC-like behavior in culture regardless of 
their tissue of origin, intriguingly suggesting that MSCs found in adult organs may arise from 
a subset of pericytes.57 Further, they demonstrated that these cells have an independent 
myogenic potential; when sorted pericytes were injected into cardiotoxin-injured skeletal 
muscles of immunodeficient mice and assessed three weeks post-injection, myotubes 
expressing human spectrin with central nuclei were identified, suggesting some pericytes 
exhibit the ability to participate in myogenesis. Interestingly, pericytes with myogenic potential 
do not appear to express the classic molecular markers of myogenesis during differentiation 
(Pax7, Myf5, or MyoD) until terminal differentiation, further distinguishing them from the 
canonical satellite cell population.58 Evidence suggests that a natural contribution of skeletal 
muscle pericytes to myogenesis occurs mostly in the postnatal period, with minimal 
contribution toward adult myogenesis, even after acute cardiotoxin-induced injury59. 
Nonetheless, satellite cells are responsive to pericyte-secreted paracrine factors promoting 
quiescence (ANGPT1) and differentiation (IGF1), suggesting a potential indirect role for 
pericytes in muscle regeneration60. Myoblasts additionally exhibit pericyte-like patterns of gene 
expression –aside from maintaining Myf5 expression- when exposed to Dll4 and PDGF-BB from 
adjacent endothelium, suggesting some “pericytes” in skeletal muscle may derive from a satellite 
cell lineage61.  Despite the apparent minimal direct contribution of pericytes to adult 
myogenesis, their ability to contribute to muscle regeneration following injection, 




population. In particular, the lack of highly specific markers for pericytes has to-date hindered 
thorough characterization and is critical for future insight into the roles of pericytes in 
myogenesis. 
A case of induced fibroblast-myoblast transition was highlighted in a landmark study by 
Davis, Weintraub, and Lasser in which transfection of MYOD cDNA into 10T1/2 embryonic 
mouse fibroblast-like cells converted them to a myoblast-like phenotype62; fibroblasts have also 
been observed to undergo myotube formation when cultured in the presence of differentiating 
myoblasts in vitro.63 Ito et al further implicated a number of coresident myoblast-expressed 
transcription factors in a myogenic transition of mouse tail-tip fibroblasts, including Pax3, Pax7, 
Mef2b, Pitx1, Mef2b, and Pitx1. These induced muscle progenitors were, however, not 
successfully expanded in culture.64 While a similar approach involving adenoviral delivery of 
MYOD demonstrated that transformed mouse fibroblasts can participate in myofiber formation in 
both immunodeficient and immunocompetent mice65, the anti-proliferative effects of exogenous 
MYOD hinders potential therapeutic applications and it is not clear that fibroblast-myoblast 
transition is a naturally occurring process in vivo. 
 Adding to the complexity of skeletal muscle regeneration is the myriad ways in which an 
arsenal of muscle ancillary cells shape the muscle microenvironment and secrete paracrine signals 
influencing cells with myogenic potential. Specifically, immune cells including neutrophils, 
monocytes/macrophages, dendritic cells, and CD4+/CD8+/regulatory T cells are now known to 
indirectly contribute significantly to skeletal muscle regeneration; while mechanisms of immune 
cell involvement in muscle regeneration are understood mostly in broad terms, they are now 




 Neutrophils -referred to as such due to Ehrlich’s observation that they tend to retain neutral 
staining solutions66- are phagocytic cells of the innate immunity and the predominant form of 
granulocytes, cells which contain membrane-bound vesicles harboring proteases and signaling 
peptides which can be exocytosed for a variety of purposes.67 They are recognized as the chief 
immune cell initially infiltrating skeletal muscle following muscle trauma, peaking in the 
immediate hours post-injury and generally declining rapidly after one day.68 Several in vitro 
studies have established that while neutrophils have roles in debris clearance following injury, they 
can cause significant damage to otherwise viable myofibers through their secretion of reactive 
oxygen species (ROS), though the contribution of neutrophils to host-cell damage in vivo is less 
clear.69,70 Interestingly, medium conditioned by injury of myofibers promotes neutrophil 
chemotaxis and ROS production in vitro71, and exercise has been shown to increase production of 
the neutrophil chemoattractant IL-8 in vivo.72 However, in VML the more probable chief 
contributor to neutrophil recruitment and priming following injury is injury-induced cell rupture 
and the resulting exposure of damage associated molecular patterns (DAMPs) recognized by cell 
surface receptors on circulating neutrophils as well as macrophages; these include the  formylated 
peptides produced by both bacteria and mitochondria (bacterially derived by endosymbiosis), 
contributing to the apparent similarities between sterile inflammation and bacterial infection.73-76 
During infections, neutrophils form structures called neutrophil extracellular traps (NETs) which 
contain locally high concentrations of cytotoxic compounds. Recent evidence suggests that 
exposure to host mitochondrial DAMPs (mtDAMPs) may impair the formation of NETs and ROS 
production, possibly driving neutrophil behavior toward phagocytosis instead of degranulation77. 
Treatment of neutrophils with mtDAMPs was also shown to induce a tolerance whereby these cells 




suggests increased NET formation and ROS production in response to endogenous mtDNA78, so 
these may represent competing processes in the wound microenvironment. Regardless, 
extracellular mtDNA has been shown to be a potentially useful prognostic indicator for 
inflammation in trauma while data remains unclear on the predictive power of extracellular formyl 
peptides.79 These aspects of neutrophil physiology do not appear to have been explored in the 
context of skeletal muscle trauma, but may participate in the degree of inflammatory response 
observed in the implantation of therapeutic biological materials containing residual DAMPs. As 
neutrophils (as well as macrophages) are capable of myofiber lysis via ROS, enzymatic inhibition 
of this process may be useful where it exacerbates muscle trauma, as in VML80.  
 Macrophages are another immune cell type responsive to muscle injury, developing from 
circulating monocytes and undergoing extravasation into muscle in response to myofiber and 
neutrophil-secreted chemokines and DAMPs. They are among the longest-lived transient residents 
of injured and regenerating skeletal muscle, increasing rapidly in number roughly 2 days post-
injury as neutrophils decline, and in some cases persisting for several weeks. While macrophages 
are well-known for their functions in pathogen and foreign body phagocytosis, evidence has 
emerged demonstrating roles in the skeletal muscle inflammatory and regenerative responses 
which vary with time course and degree of injury, evident in changes to their secretomes. 
Macrophages initially infiltrating muscle tend to have a pro-inflammatory effect, secreting 
relatively high levels of IL-12 as well as reactive oxygen and nitrogen intermediates. In typical 
mild muscle injury, a phenotypic transition toward a pro-constructive state is observed in the 
macrophage population several days post-injury, coinciding with greater secretion of IL-10 and 
TGF-β.81 These alternative macrophage phenotypes were originally categorized by Mills et al 




categorized as “M1” while the latter were referred to as “M2.” Subsequent studies have focused 
on the differing roles of these macrophage metabolic programs in disease, but recent evidence 
suggests a spectrum of macrophages phenotypes rather than a Boolean metabolic switch. In Novak 
et al’s examination of macrophage behavior following muscle laceration in mice, it is noted that 
the gene expression profiles of assessed macrophages did not correspond to the classical M1/M2 
paradigm observed in vitro; rather, they exhibited substantial heterogeneity.83 However, regardless 
of categorization, the general inflammatory-to-constructive macrophage transition in skeletal 
muscle is well attested.84 In general, interventions which promote this transition have demonstrated 
improved myogenesis and reduced fibrosis.85,86 Evidence suggests that inflammatory macrophages 
closely associate with proliferating satellite cells while those secreting anti-inflammatory factors 
associate with differentiating (MyoG+) myogenic precursors.87 Further, depleting circulating 
monocytes in mice in the preceding study completely prevented muscle regeneration, while 
depletion of macrophages at later time points following injury reduce regenerating myofiber size. 
Fascinatingly, Ceafalan et al recently demonstrated by electron microscopy that macrophages 
establish direct cell-to-cell contacts with myogenic precursor cells from satellite cell activation 
through myoblast differentiation.88 They further observed active exchange of secretory vesicles 
between these cells, suggesting potential modulation of cell behavior by well-known protein 
factors, but also epigenetic actors such as microRNAs, known to be shuttled through vesicular 
transport.89,90  
 T cells represent another important -though rather unexpected- participant in skeletal 
muscle regeneration; specifically, Burzyn et al showed that a population of regulatory T cells (Treg) 
accumulates precisely during the inflammatory-to-constructive macrophage transition. They 




express several hundred transcripts relative to their closest-expressing cousins (adipose Treg cells).  
Further, depletion of Treg cells in injured mouse muscle resulted in a disorganized pattern of 
myofiber regeneration as well as increased collagen deposition. While thorough descriptions of 
Treg roles in injured skeletal muscle have yet to be defined, evidence indicates that their absence 
results in absence of the normal M1-M2 macrophage transition, causing chronic inflammation and 
fibrosis.91 Burzyn et al recently published improved methods for isolation and characterization of 
Treg cells which will doubtlessly enable deeper study of their participation in the regeneration of 
injured muscle.92 
 Perhaps the most poorly understood yet consequential cell population in skeletal muscle 
are the fibroadipogenic progenitors (FAPs), a population of muscle-interstitial multipotent cells 
which exhibit substantial heterogeneity. Recent research has identified that FAPs expressing 
Vcam1 exhibit a pro-fibrotic gene expression profile in period following injury, and are notably 
persistent in the event of macrophage depletion.93 FAPs exhibit the capability to differentiate into 
fibroblasts and adipocytes and are the primary source of fibrosis and adipogenesis following 
muscle injury.93 Intriguingly, despite being the chief contributors to fibrosis, preventing FAP 
cells (Sca1+/CD45-/CD31-/α7-integrin-) from proliferating and differentiation through Nilotinib 
treatment impairs regeneration of muscle from acute injury, possibly due to a contribution of 
FAPs to satellite cell proliferation.94 Lukjanenko et al recently showed that FAP function is 
dramatically impaired in senescence; transcriptome profiling revealed that the ability of FAPs to 
produce WISP1 is dramatically reduced with age, and that WISP1-/- mice exhibited unusually 
small myofibers following regeneration, which was further shown to be preventable through 




skeletal muscle cell community, exhibit cross-talk with myogenic progenitors requisite for 







Table 1. FACS Gating Strategies for the Skeletal Muscle Cell Community 
 
Cell type +FACS markers -FACS markers Refs 
Dendritic cells Highly heterogeneous - No definitive gating strategy yet developed  96 
Endothelial cells CD31+ + α7-integrin+ CD45- + F4/80- 97 
FAPs Sca1+ α7-integrin- + CD31- + CD45- + F4/80-   97 
Macrophages CD45+ + F4/80+  97 
Macrophages, M1-like CD45+ + CD11b
+ + CD86+  98 
Macrophages, M2-like CD45+ + CD11b
+ + CD163+  98 
Pan-myeloid cells CD45+ + CD11b  98 
Pericytes CD146+ CD34- + CD45- + CD56- 99 
Satellite cells α7-integrin+ CD45- + F4/80- + CD31- 97 
Schwann cells P75NTR+  100-102 




B. Volumetric Muscle Loss 
 
As intimated in the previous section, skeletal muscle is host to a diverse cell community 
which coordinates a robust regenerative program following trauma leading to functional recovery; 
however, in cases where large volumes (>20%) of muscle are lost to trauma, recovery is hindered 
due to myofiber regeneration being substituted by deposition of scar tissue following a period of 
prolonged inflammation. Referred to as volumetric muscle loss (VML), these injuries contribute 
to significant disability. In a 2016 review of US Army service members with documented VML 
injuries leading to medical retirement, condition was counterintuitively seen to deteriorate with 
time; medical evaluations observed muscle-related loss of motion and pain as well as increases in 
disability rating over time103. Aside from diligent wound debridement, skin graft closures, 
generally ineffective physical therapy, and pain management, there exists no consensus standard 
of care for VML leading to appreciable functional recovery. This is compounded by the fact that 
VML injuries have a naturally heterogeneous presentation. For example, while a VML injury 
resulting from typical bullet wounds might be confined to a relatively small area with substantial 
healthy tissue remaining, those resulting from primary blast injuries are more likely to result in 
transection of major nerves, blood vessels, and bone, as well as deep tissue infections (occurring 
in 27%-77% of open fracture wounds)104-108, necessitating more aggressive treatment and 
complicating development of a one-size-fits-all solution. 
 While the general anatomy and physiology of muscle has been explored for centuries, it 
is largely in the past decade that a substantial interdisciplinary effort to address the unique 




ongoing Global War on Terror109,110. 
 
Figure 1: Research Articles Related to Volumetric Muscle Loss Indexed by PubMed 
Interest in volumetric muscle loss has increased substantially in recent years, as evidenced 
by the past decade’s positive trend in the number of new PubMed-indexed original research articles 
containing the keyword “volumetric muscle loss” over time. Beginning with a 2010 case report by 
Mase et al detailing positive functional recovery in the first tissue engineering-based treatment of 
a human VML injury, the body of VML-related literature now encompasses nearly 200 original 
research articles and case reports (Figure 1).111 This original case report applied decellularized 
porcine small intestinal submucosa extracellular matrix (SIS-ECM, a biomaterial described and 
evaluated for tissue repair by Badylak112) as a scaffold to a severe injury of the quadriceps femoris 
muscles, resulting in considerable improvement in peak torque and total work for the affected 
limb.  
 This case report was followed by establishment of standardized mouse and rat models of 




potential scaffold and cell-based therapies for VML. Implantation of lone decellularized ECM 
scaffolds similar to that of the original 2010 case report have been attempted in these models but 
have yielded mixed results. Intriguingly, Corona reported that implantation of decellularized 
muscle ECM in the rat VML model resulted in significant force recovery without concurrent 
myofiber regeneration, potentially due to the implant and resulting fibrotic mass conferring 
protection from overloading on the remaining healthy muscle115. A later study examining the 
effects of Losartan -an antihypertension medication which has been shown to reduce fibrosis in 
regenerating skeletal muscle116,117- on fibrosis and regeneration in rat VML revealed that while 
daily Losartan administration from 3 through 28 days post-injury reduced fibrosis, the functional 
outcome was a significant decrease in limb force along with no significant evidence of 
myogenesis.118 Thus, reducing fibrosis without some other compensating factor present further 
impairs muscle function in VML, possibly due to the simple obstacle of the defect to force 
transmission.  
A specific promising strategy was described by Corona et al in 2013 whereby implantation 
autologous minced muscle grafts (MMGs) at the site of injury resulted in the formation of new 
myofiber generation and reduced fibrosis, as well as an increase in net isometric torque compared 
to unrepaired limbs, though no significance was observed with when torque was normalized to 
muscle mass.119 However, the addition of voluntary wheel running following MMG treatment 
resulted in a significant increase in muscle mass-normalized isometric torque and decrease in 
intramuscular collagen; the concurrent observation of decreased macrophage marker expression 
suggested a potential augmentation of the fibrotic response and immune cell involvement in 
recovery from VML. Cross-sectional area of new myofibers within the defect area decreased with 




improvements seen, though this does not appear to have been assessed in that work and free wheel 
running does not appear to induce myofiber cross-sectional area in the tibialis anterior of mice120 
nor any increase in tibialis anterior mass in rats121.   
 The foundational rationale for exploring the use of autologous MMGs is that they are 
essentially a liberation of myofibers and consequently satellite and other muscle resident cells; 
thus, transplantation of additional regeneration-capable cells following wound debridement might 
promote regeneration whereas the inflammatory and potentially infected wound environment 
immediately following injury and preceding debridement (and thereby a likely disruption of 
resident cells) presents an obstacle to regeneration by resident satellite cells. Indeed, devitalization 
of MMGs in VML -leaving defect-adjacent cells as the sole source of myogenic precursors- results 
in no notable myofiber regeneration, whereas rats treated with unmodified MMGs exhibited 
significant myofiber regeneration.122 Further, the amount of autologous donor muscle required for 
preparing the MMG can be halved by suspending the preparation in a collagen hydrogel, leading 
to a functional outcome similar to that seen when the full MMG mass is used without a carrier.123 
Importantly, GFP labeling of MMG donor cells has demonstrated the direct and primary 
contribution of these cells to myofiber regeneration following mouse VML, with an average of 
284 GFP+ myofibers per tibialis anterior muscle at 28 days post-injury.124 Encouragingly, positive 
effects of MMG transplantation in porcine VML have been observed, suggesting the potential 
scalability of this approach to the clinic, though MMG transplantation does not yet appear to have 
been trialed in human VML.125 
 The ineffectiveness of devitalized MMGs in promoting muscle regeneration highlights the 
difficulties in applying acellular scaffolds to the treatment of VML, despite the positive 2010 case 




VML in some small clinical reports126-129, these improvements are generally modest, with 
unconvincing evidence of myofiber regeneration and lingering functional deficits compared to 
uninjured limbs, implicating fibrosis-mediated improvement in force transmission as the primary 
contributor to recovery; this is consistent with reports of a lack of myogenesis during acellular 
scaffold treatment of VML in the rat model.130 Clinical reports to date have also tended to involve 
interventions taking place months after the initial injury, complicating comparison of functional 
outcomes to existing preclinical studies which typically perform repair on the same day as injury; 
it is therefore difficult to ascertain the predictive value of the  present body of preclinical VML 
studies in estimating clinical outcomes of potential therapies. Given that immediate biomaterial 
repair of VML is an ideal not realized in the clinic, it may be prudent in to assess promising VML 
therapies in animal models with a delayed onset of repair from the time of injury. Such studies will 
yield clinically relevant insight into whether promising therapies are able to revive a muscle-
regenerative program weeks or months after the initial injury when fibrosis of the wound is 
complete. Additional clinical study is clearly needed as well, as the cumulative number of VML 
patients in clinical reports reviewed here totals only ~22 subjects, with varying sites, degrees, and 
manners of injury, though it is recognized that the natural heterogeneity of VML presents 
difficulties in acquiring subjects suitable for controlled study. 
Griesing et al evaluated two commercially available FDA-approved ECM biomaterials 
(SIS and urinary bladder matrix (UBM)) and hyaluronic acid hydrogel in the repair of VML in a 
porcine model, assessing both neuromuscular strength and transcriptome profiles by RNA-
sequencing at 12 weeks post-injury. Notably, repair with SIS or UBM resulted in functional 
outcomes equivalent to unrepaired VML, and SIS implantation was observed to result in 




overrepresented pathways by treatment group was not presented, unrepaired and repaired muscles 
exhibited substantial numbers of unique differentially expressed genes (DEGs), with 499 DEGs 
unique to the SIS-treated group alone. Interestingly, there were no significant overrepresented 
pathways for the sets of DEGs unique to each treatment group, and PCA analysis revealed 
clustering of all VML-injured groups, suggesting that the treatment strategies assessed do not alter 
global transcriptome expression in a coordinated manner at 12 weeks post-injury. 
 Aguilar et al recently performed a somewhat more detailed transcriptome profiling of VML 
and autologous minced muscle autograft repair in the rat model across time points ranging from 3 
to 14 days post injury. Interestingly, MM repair of VML resulted in a similar transcriptional 
trajectory as unrepaired VML, showing a persistent upregulation of inflammation and fibrosis-
related transcripts in response to VML (1925 total DEGs at 3 days post injury to 16 DEGs at 28 
days), though a detailed analysis of DEGs in the MM group in comparison to the VML set was not 
presented. It is therefore unclear from this work whether there any distinct transcriptional behavior 
occurring in the MM treatment group which could contribute to the improved functional outcome 
relative to untreated VML. Regardless, it is clear that MM alone does not change the overall 
fibrotic fate of the VML wound environment. 
 An underexplored aspect of VML is how the neuromuscular unit is affected by severe 
muscle injury, with what degree ostensibly effective preclinical biomaterial therapies are 
modulating peripheral nerve repair remaining largely unclear. It is evident that if substantial injury 
occurs to axons and neuromuscular synapses in the largely intact muscle adjacent to a VML injury, 
that muscle may atrophy from disuse without timely repair, and whether this is a common 
occurrence in VML remains unclear. Corona et al recently advanced this area considerably by 




disproportionate degree of motoneuron axotomy in the tibialis anterior, with an average of 69% of 
motoneurons innervating the tibialis anterior being subjected to axotomy131,132. This finding was 
based on pre-surgical and post-surgical labeling by intramuscular injection of Alexafluor-
conjugated Cholera Toxin Subunit B, which is commonly used as an approach for both retrograde 
and anterograde labelling of neurons and their associated axons133. CTB is principally a ligand for 
the GM1 ganglioside present on the surface of neurons, which is endocytosed following CTB-
binding, allowing for imaging of the entire neuron and axonal tract134,135. Thus, this specific assay 
may be a useful indicator of axotomy for future investigations utilizing animal VML models, 
though Corona et al did not specify in their publication the exact area of the spinal cord assessed. 
 The finding of motoneuron axotomy in VML, its correlation with muscle force deficits, 
and apparent persistent lack of axon recovery in the weeks following VML injury suggests that 
the neuromuscular units of ostensibly intact adjacent muscle tissue are negatively impacted, and 
consequently that this neuromuscular disruption has a role in long term VML deficits. It has long 
been known that axotomy of muscle-innervating nerves results in significant atrophy of the 
formerly innervated muscle tissue136, and therefore a goal of successful VML therapies should be 
to address damage to the neuromuscular unit where it occurs, by promoting the regeneration of cut 
axons and then formation of functional neuromuscular junctions; the key chemical synapses 
mediating the transduction of an action potential into muscle contraction. The general outcomes 
of muscle innervation following nerve injury have been studied in some depth in the plantar 
muscles such as the tibialis anterior assessed in most preclinical studies, often through crush of the 
sciatic nerve, which contains distal branches innervating muscles of the lower limbs. 
 One proposed approach to accelerating peripheral nerve repair is the application of 




axonal regeneration.137-139 Notably, it has been shown in rats that it is specifically brief low 
frequency stimulation (2 Hz) which promotes regeneration, with higher frequencies (200 Hz) 
resulting in less regeneration of sciatic nerve following injury.140 Asensio-Pinilla et al 
demonstrated that a combination of treadmill running (5 meters per minute for 2 hours daily) with 
a one-hour electrical stimulation immediately following injury (3 volts, 20 Hz) resulted in 
significantly increased muscle innervation and number of regenerated axons compared to control 
rats and those subjected to chronic (1 hour daily) electrical stimulation.141 Further, similar positive 
outcomes were observed in a clinical pilot study in which patients undergoing carpal tunnel release 
surgery were subjected to an acute electrical stimulation (1 hour, 4-6 volts, 20 Hz) of the median 
nerve142; quantification of axonal regeneration by motor unit number estimation (MUNE) revealed 
that patients subjected to electrical stimulation following surgery on average exhibited a 
remarkable comparable-to-normal innervation at 12 months post-surgery, while patients 
undergoing surgery only experience no significant increases in number of motor units when 
evaluated 3-12 months post-surgery. Brief electrical stimulation has also been shown to improve 
outcomes in recent clinical application toward shoulder dysfunction143, recovery following digital 
nerve transection144, as well as reduce pain145. However, the literature is less clear on whether such 
an approach would yield similar results when it is the downstream muscle-nerve unit subjected to 
direct injury rather than an upstream nerve. In contrast to much of the literature, limited reports 
suggest that electrical stimulation can have an adverse effect on the neuromuscular unit in the 
plantar muscles146, or may prevent muscle atrophy while not appreciably affection 
reinnervation147. The molecular changes potentially mediating the effects of electrical stimulation 
have not been extensively characterized, but several studies have observed significant increases in 




in vitro evidence suggests that exogenous BDNF promotes neurite outgrowth through activation 
of JAK/STAT signaling152 as well as neuron survival153. The general trend of promising preclinical 
and clinical outcomes observed in the application of brief electrical stimulation toward restoring 
muscle innervation following upstream nerve injury invites preclinical exploration of the approach 
as an additional low-risk therapy for VML.   
 Biomaterials-based approaches to nerve regeneration have been extensively discussed in 
the recent neuroregenerative literature.154-159 Nerve grafts are used in the clinical repair of 
peripheral nerve injury but, like muscle grafts, involve limited availability and the possibility of 
immunological reaction; considerable interest therefore exists in generating synthetic materials to 
promote nerve regeneration. Typically taking the form of a polymeric tube which is bridged across 
a nerve defect, successful nerve regeneration across defects of 10-30 mm are is well attested. 
Greater yet distances have been bridged through the use of collagen sponges, with one study in 
dogs indicating successful regeneration across an 80 mm nerve defect.160 While biomaterials 
specifically targeting peripheral nerve regeneration in the context of VML are not yet described, 
evidence does exist that the class of allogeneic decellularized scaffolds that are commonly assessed 












C. Bioengineering Regenerative Materials In Vitro 
 While decellularized allogeneic and xenogeneic scaffolds are popular for their 
demonstrated potential in the repair of several tissues including skeletal muscle, the limited 
availability of cadaveric tissue and the potential for immune reaction to foreign epitopes are 
limiting factors in their application, particularly toward tissues which are not scar-tolerant or in 
which a foreign body reaction could prove fatal; such was the case in the implantation of Synergraft 
decellularized porcine heart valves, resulting in the death of three children due to inflammation-
induced implant failure and subsequent explantation of the valve from the fourth child.162  
 A potential alternative for decellularized cadaveric tissues exists in the rapidly developing 
field of in vitro tissue engineering. While the prospect of producing whole functioning organs in 
vitro remains somewhat elusive, the production of extracellular matrix (ECM) -the foundational 
structure of any decellularized cadaveric tissue- in vitro is an existing technology. However, 
typical ECM production involves the culture of cell monolayers and the gentle mechanical or 
enzymatic dissociation of the cell/ECM sheet from its substrate163,164. Alternatively, a promising 
approach enabled by advances in material science in the past decades is the development of cell 
culture systems using temperature-responsive polymers as the cell substrate. Poly(N-
isopropylacrylamide) (NIPAAM) is a polymer which dissolves in water below 32 °C due to 
conformational changes induced in the polymer chain induced by hydration165; Yamada and Okano 
et al demonstrated that this property allowed for deadhesion of hepatocytes from a NIPAAM-
grafted polystyrene surface.166 Interestingly, cells generally do not adhere efficiently to thick (>30 
nm) layers of NIPAAM due to insufficient dehydration of polymer chains, resulting in insufficient 
hydrophobicity for cell adhesion.167 Thus, constructs for thermally responsive deadhesion of cells 




  Regardless of substrate composition or method of ECM retrieval, conventional 2D culture 
has significant limitations in the retrieval of cell products. Principally, the relatively low surface 
area of flat culture flasks results in a low adherent cell density and protein productivity relative to 
that exhibited in suspension culture. For example, a typical 75 cm2 cell culture flask may achieve 
approximately 100,000 cells/cm2, utterly dwarfed by the extreme cell densities achievable (in 
excess of 100*106 cells/mL) with suspension culture of the Chinese hamster ovary (CHO) cells 
currently used for 70% of industrial antibody production168.  While it is intuitive that adherent cell 
systems are inherently less productive than suspension culture, most cell types of tissue 
engineering interest are anchorage-dependent, and bioreactor systems now exist which leverage 
high surface area substrates to maximize cell density and productivity.  
 Among the most productive of these is the hollow fiber bioreactor. Knazek et al described 
in 1972 the culture of fibroblasts on cellulose acetate capillaries, yielding 1 mm diameter growths 
following 28 days of incubation; the authors remarked the high cell densities culturable in a such 
a high surface area-to-volume-ratio system and thus the potential to engineer tissues in vitro.169 In 
the decades since, hollow fiber membrane-based bioreactor systems have seen commercial 
application for the production of monoclonal antibodies in addition to their ubiquitous application 
in industrial separations processes.  Hollow fibers are attractive as cell culture substrates due to 
their high surface area, tunable pore diameters governing their transport properties, and a wide 





Figure 3: Example of a Simple Hollow Fiber Membrane Bioreactor 
The typical hollow fiber membrane bioreactor (Figure 3, example by author) takes the 
form of a cylindrical cartridge in which rest hundreds of individual hollow fibers sealed at each 
end by a biocompatible resin, with anchorage-dependent mammalian cells cultured on the outer 
surfaces of the membranes and medium pumped through the extracapillary space of the 
cartridge. While the assembly of such a bioreactor seems in principle relatively straightforward, 
the choice of membrane substrate, perfusion rate, atmospheric conditions, fiber spacing170, and 
cartridge material have significant effects on cell survival, proliferation, and productivity. 
Hollow fiber bioreactor development is an active area of private development, with several 
recent patents on the matter171-174 and commercial availability of ready-to-use bioreactor systems 
such as those produced by FiberCell Systems, with surface areas of up to 1.2 m2 and 
corresponding cell densities of up to 5.0E10 cells in a single 60 mL cartridge175. 
 Hollow fiber bioreactors have been of interest for use in tissue production as artificial 




of their transport properties.176-178 In the context of ECM production, Potter et al demonstrated 
the ability to grow 1 mm-thick masses of cartilage179 after four weeks of culturing embryonic 
chick chondrocytes in a hollow fiber bioreactor system, with development of tissue monitored by 
MRI. Oxygen transport is considered to be the most limiting factor in the bioreactor culture of 
mammalian cells, including within the hollow fiber bioreactor.180 For example, when a 
membrane-anchored biofilm grows -as with the development of cartilage in the Potter study- the 
diffusive transport of oxygen and key medium nutrients across the membrane is hindered. Given 
the short distances across which solely diffusive transport of oxygen across tissues is relevant 
(~1 mm)181, the addition of convective transport of oxygen is critical182, as illustrated by Ku et 
al’s observation that as much as much as 25% of the dissolved oxygen in fresh medium is 
















D. Fabrication, Tuning, and Characterization of Hollow Fiber Membranes  
 Hollow fiber membranes are ubiquitous in industrial separations for their ability to separate 
components of various streams based on size exclusion via layers of selective pores, with an 
application of transmembrane pressure and concentration gradients being the primary driving 
forces for permeation through the membrane. Hollow fibers commonly manifest as the asymmetric 
type, characterized by an exofacial layer of pores and a lumen-facing layer of pores bridged by a 
sponge-like support layer, as visible in this example of a NIPS polysulfone hollow fiber membrane 
fabricated by the author (Figure, 2 scale-bar = 100 µm). Hollow fibers are engineered via a tunable 
process known as phase inversion. Phase inversion is a process which leads to the phase transition 
of a polymer solution from liquid to solid, precipitating a porous membrane.183 It is one of the most 
prominent methods of membrane fabrication and can occur by several distinct mechanisms; these 
include nonsolvent-induced phase separation (NIPS), thermally induced phase separation (TIPS), 
evaporation-induced phase separation (EIPS) and vapor-induced phase separation (VIPS).  NIPS-
driven phase inversion occurs by exchange of nonsolvent for solvent upon immersion of a polymer 
solution in nonsolvent, while TIPS causes phase separation by extrusion of a heated polymer 
preparation into a cooling bath.184-187  VIPS can be considered a special case of the NIPS 
mechanism, wherein the nonsolvent used is in the vapor phase.188,189 Specific manufacturing 
processes can exploit combinations of these mechanisms to varying degrees. One of the more 






Figure 2: Example SEM micrograph of a NIPS-Cast Hollow Fiber Membrane 
Wet spinning involves the extrusion of dope (polymer) and bore solutions through a 
spinneret, after which the combined streams enter an external coagulant (usually water), leading 
to the precipitation of a solid hollow fiber membrane by phase inversion; it is thus analogous to 
the immersion precipitation process for fabricating flat membranes. There is frequently an “air 
gap” between the outlet of the spinneret and the surface of the external coagulant; when an air 
gap is used, the process is termed dry-jet wet spinning. The phase inversion process begins 
immediately upon exit of the two streams from the spinneret, first primarily by evaporation of 
the solvent (if an air gap is present) and then by bulk exchange of solvent and nonsolvent (NIPS-
driven) or cooling of a heated polymer dope (TIPS-driven) as the nascent fiber enters the 
coagulant bath. Extrusion can be achieved either through the use of pumps or a pressurized inert 
gas, wherein the pressures required for extrusion differ depending on factors such as the 






Performance of hollow fiber membranes in size exclusion separations is often expressed in 
terms of a molecular weight cut-off (MWCO). The MWCO of a membrane is generally defined as 
the molecular weight of a compound in solution for which a membrane would reject greater than 
90%.190 Ultimately, the relation between molecular weight and rejection is only an approximation 
for which there are many exceptions, as rejection also depends on the specific structure and 
electrostatic characteristics of molecules; this is elegantly illustrated by the fact that relatively large 
plasmids can be transported through ultrafiltration membranes via elongation as they converge on 
pores, a result that would not be expected if molecular weight were the principal factor.191 Despite 
this, MWCO is a useful property when used in reference to a common class of molecules, and is a 
ubiquitously reported  property of membranes intended for protein separations. Determination of 
MWCO is often accomplished by evaluating the membrane separation of polyethylene glycols of 
varying molecular weight.192,193 While MWCO provides a practical rule of thumb for the end user, 
analysis of membrane structure and composition are necessary for a predicting and tuning 
membrane performance during research and development. 
The dimensions, distributions, and frequencies of pores dictate the size exclusion properties 
of a membrane. In a biopharmaceutical context, membranes of several different nominal pore sizes 
are used at different stages of separation, in part to prevent unnecessary fouling of highly selective 
membranes by large debris removable by less selective membranes. Microfiltration membranes 
(0.1 – 1 µm pores) or microsieves are commonly used to remove bacteria from a stream, while 
ultrafiltration membranes (1-100 nm) can be used to effectively separate viruses and high 
molecular weight components for purification of protein. Adsorption of protein within or adjacent 




a membrane least prone to fouling in the specific application. Thus, characterizing and tuning pore 
size distribution are critical aspects of membrane design. 
Scanning electron microscopy (SEM) is sometimes used to observe pore size, but comes 
with several important caveats. Most importantly, SEM generally assesses a very small area of 
sample which may not be representative of the whole. Further, these analyses are most commonly 
made based on surface level images, and so the pore diameter determined by the investigator is 
typically of the pore opening rather then the pore throat that is most relevant to transport. 
Additionally, a more minor consideration is that the sputter-coating process for preparation of 
SEM samples may result in a smaller apparent pore size, though this is most relevant in the case 
of nanofiltration pores (<10 nm). Mercury porosimetry has been used for decades for determining 
the pore size distribution of a great variety of materials, including membranes. It is based on an 
inverse relation between the pressure required to push mercury into a pore and the size of that pore, 
as described by a modified form of the Young-Laplace equation referred to as the Washburn 
equation. However, there are several important caveats to consider regarding the use of this 
technique for membranes; first, the high pressures required to force mercury through a membrane 
may damage the membrane and thus alter its pore size distribution. Secondly, mercury porosimetry 
does not measure the most constricted portion of a pore channel; rather it determines the diameter 
of the pore’s entrance, which is not as important to transport as the former property. It also does 
not distinguish between dead-end pores (which do not function in size exclusion) and continuous 
pores. Further, the instrumentation –while readily available from several commercial sources- can 
be quite expensive compared to alternative techniques. However, mercury porosimetry does have 




 LLDP is an attractive technique for the measurement of ultrafiltration membrane pores, as 
it uses relatively low pressures compared to those required for mercury intrusion, avoiding 
compaction of membranes that could produce erroneous results, and generally measures the 
diameter of the continuous pores that are relevant to transport.194 Further, it also evaluates the 
membranes while wetted, as they might be under operating conditions.195 LLDP operates through 
the displacement of a wetting liquid in the membrane by a “displacing” liquid. As pressure is 
increased stepwise, the Hagen–Poiseuille equation can be used to generate a pore size distribution 
based on flux of displaced water.196 Another useful aspect of LLDP is that it can be used to estimate 
the molecular weight cutoff (MWCO) of ultrafiltration membranes, as described by Calvo et al.197 
Despite the utility of LLDP, any interactions between the liquids used and the membrane that may 
affect its pore size distribution (e.g., swelling) must be considered.198  
 Nitrogen adsorption-desorption is generally considered the gold-standard technique for 
analysis of surface area and pore diameter, with widely available commercial equipment. In 1938 
Brunauer, Emmet, and Teller published their method for relating the adsorption of gas to the 
surface area of the adsorbent.199 Though the theory is based on the Langmuir model of adsorption 
which makes the assumption that the adsorbent is of a planar geometry200, the BET theory remains 
the industrial standard for determination of surface area. In 1951 Barrett, Joyner, and Halenda 
described a procedure (BJH) for relating gas adsorption to pore diameter based on the Kelvin 
equation.201 It is remains commonly used, but is criticized for resulting in high error as nominal 
pore size decreases.  
Despite various advantages of the aforementioned techniques -including their broad use in 
literature enabling convenient comparison- common to all of them is the necessity of fairly 




pore diameter who are not specialists in pore characterization. Evapoporometry is a novel method 
for calculation of pore diameter distribution which relates the instantaneous evaporation rate of a 
fluid from a saturated sample to the diameter of instantaneously draining pores via a derivation of 
the Kelvin equation: 







where 𝑦 is surface tension, V is vapor molar volume, R is the universal gas constant, T is absolute 
temperature, 𝑊𝐴0 is the instantaneous evaporation rate and 𝑊𝐴0
°  is the average rate of evaporation 
for a layer of the volatile fluid initially overlying the sample.  Evapoporometry is most notable for 
the fact that it requires only materials that are ubiquitous in most engineering laboratories: an 
analytical balance with a 10 µg resolution and PC interface, a PTFE test cell in which to secure a 
fluid saturated sample, and a volatile fluid of choice. Evaporative mass loss is to molar evaporation 
rate (𝑊𝐴0 and 𝑊𝐴0
° ) and used with surface tension (of the fluid), vapor molar volume, and absolute 
temperature to yield the pore diameter in meters for pores draining at a particular instant. 
Importantly, evaporation proceeds in descending order of pore size due to supersaturation of vapor 
for all pores smaller than those draining at any instant. However, the method incurs some 
limitations, chiefly an upper limit of pore detection of ~300 nm202, the possibility of fluid-sample 
interactions, and an unstandardized graphical analysis approach for data analysis which has in 
practice lead to considerable user-to-user variation in analysis of identical datasets. Further, the 
method has largely been validated with idealized flat sheet membranes with well defined pores, 
and it remains whether the precision of the technique is maintained when used for more irregular 
samples such as solvent-cast membranes or ion exchange resins. Finally, given the known 




between evaporated mass and surface area, but this has not been specifically evaluated in the 
literature. A software-aided approach to address challenges in evapoporometry data analysis is 

























 The primary objectives of this work are threefold: to evaluate the feasibility of a sacrificial 
hollow fiber membrane cell culture approach for the production of matrix scaffolds targeted toward 
VML, improve the methodology for characterizing the dimensions of pores influencing the 
performance of membranes in industrial separations and cell culture, and to develop a better 
understanding of the biomolecular processes mediating recovery in biomaterial-based repair of 
VML.  
 We first demonstrate the isolation of bulk threads of ECM in vitro through the intraluminal 
seeding of ECM-productive mammalian cells in solvent-degradable hollow fiber membranes. We 
further characterize the mechanical and biochemical properties of ECM isolated from sacrificial 
scaffolds, demonstrate its assembly into implantable meshes, and show that it supports the viability 
of mammalian cells in vitro. We additionally provide a separate detailed description of methods 
for producing bulk ECM by this approach, from membrane fabrication through implant processing. 
 In the interest of increasing the accessibility of pore dimension analysis beyond the 
membrane specialist, we develop an open-source Python GUI tool for the analysis of 
Evapoporometry data. We show that software-aided analysis yields precise analysis of pore 
diameter for well-characterized membranes as well as ion exchange resin, in agreement with 
analysis by gold-standard methods. We further demonstrate the initial application of this method 
for evaluating relative differences in surface area.  
 Finally, we perform the first transcriptomic analysis by RNA-sequencing of a combined 
decellularized skeletal muscle (DSM) plus autologous minced muscle (MM) VML repair approach 
which in our previous work has been shown to restore over 50% of muscle contractile force lost 




with force recovery in the two-week period following injury are primarily of a neuroregenerative 
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The therapeutic potential of biological scaffolds as adjuncts to synthetic polymers motivates 
the engineering of fibers formed using the extracellular matrix (ECM) secreted by cells. To 
capture the ECM secreted by cells during in vitro culture, a solvent degradable hollow fiber 
membrane (HFM) was created and utilized as a cell culture platform. 3T3 fibroblasts were 
injected into the narrow (0.986 ± 0.042 mm) lumina of mesoporous polysulfone HFMs and 
maintained in culture for up to three weeks. Following cell culture, HFMs were dissolved 
using N-methyl-2-pyrrolidone (NMP) and the accumulated ECM was collected. The ECM 
retained the filamentous dimensions of the HFM lumen. The process yielded up to 0.89 ± 0.20 
mg of ECM for every mm of HFM dissolved. Immunofluorescence, second-harmonic 
generation microscopy, and tandem mass spectrometry indicated the presence of an array of 
ECM constituents, including collagen, fibronectin, and proteoglycans, while FTIR spectra 
suggested thorough HFM material dissolution. Isolated ECM fibers, although fragile, were 
amenable to handling and exhibited an average elastic modulus of 34.6 ± 15.3 kPa, ultimate 
tensile strength  of 5.2 ± 2.2 kPa, and elongation-at-break of 29% ± 18%. ECM fibers 
consisted of an interconnected yet porous (32.7% ± 5.8% open space) network which 
supported the attachment and in vitro proliferation of mammalian cells. ECM fibers were 
similarly synthesized using muscle and astrocyte cells, suggesting process robustness across 
different cell types. Ultimately, these ECM fibers could be utilized as an alternative to 







 Woven surgical meshes are extensively utilized for the repair of damaged tissues. Each 
year over 1 million surgical meshes are implanted worldwide1. These meshes are typically 
fabricated using synthetic polymer fibers, the most common being polypropylene. Biomaterial 
fibers are highly versatile materials that can be woven into a range of implant geometries 
(meshes, tubes, ropes) using high throughput fabrication methods developed and routinely used 
by the textiles industry. However, the dramatic rise in the use of surgical meshes has been 
matched by a similar rise in serious post-surgical complications and product recalls2-4. The 
complications associated with surgical meshes appear to be a direct consequence of the host 
response to synthetic polymer implants5. Specifically, the aggressive foreign body response, 
characterized by fibrotic tissue formation combined with the chronic activation of immune cells 
at the site of implantation, appears to be a serious roadblock to clinical success6. In fact, the 
aggressive fibrotic response directed against implanted synthetic materials requires that surgical 
meshes be applied only where scarring at the site of implantation can be tolerated. For instance, 
in cases where woven meshes are used to repair hernias the dense scarring response strengthens 
the repair site7. However, for many regenerative applications (muscle, vessel, nerve), the 
restoration of native tissue structure is the goal, and therefore the disorganized scarring 
associated with the foreign body response is a severe disadvantage. Ultimately, while fibers 
have tremendous potential as the raw material for biomedical implants, synthetic polymer fibers 
are unlikely to find clinical utility for the repair of non-connective tissue types. For cardiac, 
vascular, nervous, and muscle tissue repair, the need exists for a biomaterial fiber that can be 





Extracellular matrix (ECM) is a network of biomolecules secreted by all somatic cells of the 
body which functions as both a physical support for tissues and a reservoir of chemical cues 
which guide cell differentiation, migration, and tissue remodeling8. ECM is noted for its 
regenerative capacity, with several clinical studies having demonstrated the efficacy of ECM-
based grafts for repair of heart, skin, cartilage, and other tissues9-12. Of particular relevance to 
woven meshes, published evidence suggests that fibers containing extracellular matrix (ECM) 
molecules mute the foreign body reaction and enhance regeneration13,14. Specifically, Badylak 
and colleagues have shown that ECM-coated synthetic meshes reduced the fraction of pro-
inflammatory M1 macrophages at the site of implantation and that this change enhanced tissue 
remodeling. However, while composite ECM/synthetic fibers may delay a foreign body 
response, they are unlikely to eliminate it completely. As the ECM degrades and the underlying 
synthetic material interface is exposed to the immune system, a foreign body reaction will 
eventually be initiated. We suggest that fiber built entirely from ECM -carrying an arsenal of 
macromolecules relevant to wound-healing-is a logical next step toward the development of 
whole ECM meshes which may have clinical utility as an adjunct to synthetic polymers. 
 To create ECM fibers, our group has previously explored methods to farm the ECM 
secreted by populations of mammalian cells during growth in culture15,16. The creation of ECM 
fibers is predicated by a simple principle; cells have the ability to produce ECM, and the 
primary challenge is to develop methods to concentrate and collect the molecules that they  
secrete. Toward this end, we have explored a technique to facilitate the accumulation of 
cellsecreted molecules using hollow fiber membranes (HFMs) as a cell culture platform. When 
the lumen is seeded with cells, the semipermeable HFMs trap the large cells and secreted ECM 




for cell culture is not unique by itself, semipermeable HFM’s have been used as platforms for 
the cultivation, implantation, and immuno-isolation of hepatocytes and pancreatic islet cells17,18. 
What is unique is the sacrificial role of the HFM. Rather than being a permanent component, it 
instead serves as a temporary platform used to capture and collect cell secreted ECM. Once 
sufficient ECM has been collected, the synthetic HFM can be dissolved, leaving behind only the 
accumulated ECM which retains the shape of the lumen. In this study, we describe this novel 
scheme for the production of ECM fibers using sacrificial HFMs as a cell culture platform, and 
present the characterization results for several key ECM fiber physical and chemical properties. 
B. Materials and Methods 
Preparation of Hollow Fiber Membranes  
 Mesoporous polysulfone HFMs were manufactured using a common dry-jet wet spinning 
method19 (Table 1). Polysulfone pellets (35kD, Sigma, St. Louis MO) were dissolved in N-
methyl-2-pyrrolidone (NMP, 17.8 w/w%) for three days at 25 °C. Polysulfone (PSF) dope 
solution and a bore solution of NMP in deionized water (15, w/w%) were extruded through a 
spinneret (AEI) using pressurized N2. Flow of dope and bore solutions from the spinneret into 
an air gap and subsequent water bath resulted in precipitation of polysulfone fibers by 
nonsolvent-induced phase separation (Figure. 1). HFMs were stored in deionized water for three 
days, with water exchanged once per day for removal of residual solvent. 
Cell Culture  
To facilitate cell culture, HFMs were sterilized in 70% ethanol for 24 hours and incubated in a 
solution of bovine plasma fibronectin (20 μg/mL) at 37 °C for one hour, after which they were 
cut using sterile scissors to lengths of 6 cm for cell-seeding. Frozen NIH/3T3 fibroblasts 




confluent in DMEM/F12 containing 10% (w/v) fetal-bovine serum (FBS), 1% L-glutamine, and 
1% penicillin-streptomycin. Confluent cultures were disassociated using 0.25% Trypsin-EDTA 
prior to centrifugation. Pellets were resuspended in DMEM/F12, with cell density counted using 
a hemocytometer. Cells were seeded into the lumina of HFMs at a density of approximately 
20K cells/cm of fiber length using a sterile 21-gauge needle and syringe. 
 All cell seeded HFMs were cultured for durations of either one or three weeks in 
DMEM/F12 supplemented 10% (w/v) FBS, 1% L-glutamine, 1% penicillin-streptomycin, 0.285 
mM L-ascorbic acid (Sigma), 0.5 mM L-ascorbic acid 2-phosphate (Sigma), and 5 ng/mL 
human TGF-β1 (Peprotech, Rocky Hill, NJ). At the completion of the culture period, cell-
seeded HFMs were dissolved in 99.5% NMP for three days, with NMP exchanged once per 
day. The remaining cell-derived material (ECM fiber) was collected, rinsed for 48 hours in DI 
water, and characterized. A subset of HFMs were seeded and cultivated with rat astrocyte and 
skeletal muscle fibroblast cells to evaluate process robustness across cell types. Astrocyte and 
muscle cells were harvested via methods approved by the University of Arkansas Institutional 
Animal Care and Use Committee (IACUC). 
Characterization  
 Transverse cross-sections of naïve polysulfone HFMs were fractured in liquid nitrogen 
and imaged by SEM to visualize membrane morphology. HFM inner diameter, outer diameter, 
and wall thickness were measured from microscope images collected from representative 
samples (n =10). The pore-size distributions of HFMs were determined using evapoporometry 
and guided by published protocols20–22. HFMs were fixed to plastic test cells (n = 3) using an 
epoxy resin, immersed in 99.5% isopropanol, and mass loss due to evaporation of isopropanol 




described by Krantz et al22. Evapoporometry was chosen as the technique for probing pore size 
in this investigation, as it avoids the application of significant pressure to a sample, is non-
destructive, and has been applied successfully toward the analysis of the selective layers of 
pores between 4 nm to 365 nm in asymmetric membranes, including hollow fiber membranes 
similar to those produced in this investigation23, 24. 
 The effectiveness of the NMP dissolution method was assessed using attenuated total 
reflectance Fourier transform infrared spectroscopy (ATR-FTIR) with a resolution of 8 cm−1 
and a scanning range of 900–1800 cm−1. ATR-FTIR spectra for representative NIH/3T3 
derived ECM fibers, cultured polysulfone HFMs, and naive HFMs were analyzed for the 
presence of sulfonyl groups and aromatics characteristic of polysulfone, as well as protein 
characteristic amide bands. 
 In preparation for characterization, NIH/3T3 derived ECM fibers were decellularized 
using a detergent based protocol25. Samples were rinsed for 90 min in Tris-HCL (10mM, 
pH8.0) with 1% EDTA and 10KU/ml aprotinin 4°C with agitation. Samples were then soaked 
in 0.1% sodium dodecyl sulphate (SDS) in Tris-HCL buffer for 24 hours at room temperature 
with agitation. To remove nuclear remnants samples were then incubated for 3 h in reaction 
buffer containing 50U/mL deoxyribonuclease I and 1U/mL ribonuclease A in 10mM TrisHCl 
(pH 7.5) at 37°C with agitation. To assess decellularization effectiveness, treated and control 
samples (n=3/sample group) were fluorescently stained for the presence of the cytoskeletal 
protein actin using phalloidin (1:40, Sigma). Cells were counterstained with the nuclear reagent 





 Decellularized NIH/3T3 derived ECM fibers were rinsed in deionized water and weighed. 
Yields were calculated relative to HFM length (mg/mm). Astrocyte and muscle cell derived 
ECM fiber yield was similarly measured. To examine the internal structure, hydrated NIH/3T3 
ECM fiber samples (n=3) were sectioned (7 μm) with the aid of a cryostat (Leica), mounted 
onto microscopic slides, stained with hematoxylin and eosin and imaged. From the digital 
images, the porosity (% open area) was calculated from transverse ECM fiber sections with the 
aid of image analysis software (ImageJ), through subtraction of freehandbounded pore area 
from total section area and dividing the difference by total section area to yield porosity. To 
visualize fiber surface features, NIH/3T3 derived fiber samples were frozen, lyophilized, and 
imaged using scanning electron microscopy (SEM). The SEM imaging of lyophilized samples 
was motivated by the anticipated use of freeze-drying to prepare materials for storage and 
implantation. 
 HFM and decellularized NIH/3T3 ECM fiber mechanical properties were measured with 
the aid of a uni-axial mechanical testing device (5994, Instron, Norwood, MA) using techniques 
familiar to our group16, 26, 27. Hydrated (PBS, pH = 7.4) samples (gauge length = 1 cm) were 
deformed at a constant strain rate of 10%/min until failure using a 1N load cell while load and 
displacement values were recorded at 10 Hz. Prior to testing, sample (n = 4/sample group) fiber 
diameter was measured using digital calipers. For each sample, engineering stress versus strain 
curves were generated from load and elongation data. Strain was determined using grip 
displacement values. From each curve, the tangent modulus was calculated using a linear fit to 
the region of the stress-strain curve extending from the end of the toe in region, approximately 
10% and 0.5% strain for ECM and HFM fibers respectively, to the point of sample failure. The 




 NIH/3T3 ECM fibers were assessed for the presence of accumulated ECM constituent 
proteins by immunofluorescence. Representative fibers were immunoreacted for the presence of 
cellular fibronectin (Mouse IgM, 1:500, Sigma) followed by the appropriate fluorescently 
labeled secondaries (1:500, Alexafluor, Life Technologies). Samples were counterstained with 
the nuclear staining reagent DAPI, and then microscopically imaged using an Eclipse Ci-S 
microscope with D-FL epifluorescence attachment (Nikon, Tokyo, Japan). The accumulation of 
organized fibrillary collagen within ECM fiber samples was assessed using label free second 
harmonic generation microscopy (Ultima Investigator, Bruker Inc., Middleton, WI) [25]. 
 NIH/3T3 ECM fiber proteomic composition was further assessed using tandem mass 
spectrometry (MS/MS). MS/MS was performed with the aid of the University of Arkansas for 
Medical Sciences proteomics core facility. Samples were hydrated in acetonitrile, digested with 
trypsin in 100 mM ammonium bicarbonate at 37°C for 12–16 hours. Tryptic peptides were 
separated by reverse phase Jupiter Proteo resin (Phenomenex) on a 200 × 0.075 mm column 
using a nanoAcquity UPLC system (Waters). Eluted peptides were ionized by electrospray 
(2.15kV) followed by MS/MS analysis using higher-energy collisional dissociation (HCD) on 
an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific, Waltham, MA) in top-speed 
data-dependent mode. Proteins were identified by comparison to a proteomics database 
(Mascot, Matrix Science). Scaffold proteomics software was used to verify MS/MS protein 
identification, with identifications accepted if established with a less than 1% false discovery 
rate as determined by Scaffold’s local FDR algorithm. 
 A direct contact assay was employed to assess cellular attachment and proliferation upon 
ECM fiber materials. In preparation for cytotoxicity assays, decellularized NIH/3T3 ECM 




sterilized for 24 hours in 70% ethanol. NIH/3T3 cells were seeded onto each sample at a density 
of 10 K cells per sample, and cultured in DMEM-F12 with 10% (w/v) FBS, 1% L-glutamine, 
and 1% penicillin-streptomycin. Following 72 hours of culture, samples were assayed for cell 
viability and death via Calcein AM (2 μM in PBS) and EthD-1 (4μM in PBS), respectively. 
Calcein stained ECM fibers were microscopically imaged and assessed for cell coverage. 
 In vivo host response was examined using a subcutaneous implant site. In vivo 
biocompatibility was assayed at 2 and 6 weeks post-implantation time points. Mature male 
Sprague Dawley rats (300+g) were used (Envigo, IN). All surgical procedures were performed 
in accordance with protocols approved by the University of Arkansas Institutional Animal Care 
and Use Committee. Anesthesia was induced using isoflurane (2–4%) in oxygen. The 
subcutaneous implant site was surgically exposed through a 2 cm left-right incision placed 
caudal to the scapulae. A subcutaneous pouch was created in each animal by blunt dissection. A 
single NIH/3T3 ECM sample was implanted into each pouch (approximate implant size 10mm 
diameter). Incisions were closed using surgical adhesive (VetBond, 3M). Following surgery all 
animals were housed in the University of Arkansas Central Laboratory Animal Facility. At the 
prescribed time-points all animals (n=3/ timepoint) were euthanized via inhalation of carbon 
dioxide. The implant site with surrounding soft tissue was harvested, fixed in 4% 
paraformaldehyde, paraffin embedded, sectioned (10um), and stained with H&E. Stained 
sections were imaged and examined for evidence of inflammation and material degradation. 
Statistical Methods 
All data are represented as mean and standard deviation. The effect of cell type and culture 




hoc comparisons were made using Tukey’s test. A standard 0.05 level of significance was used 
for all statistical tests. 
C. Results 
Hollow fiber membranes (HFMs) fabricated by the dry-jet wet spinning technique (Fig. 1) were 
of the asymmetric type, with selective inner and outer skin layers supported by a highly porous 
intermediate layer (Figure. 2). Approximately 100 meters of HFM were fabricated from 300 mL 
of 17.8 w/w% polysulfone in N-methyl-2-pyrrolidone. Evapoporometry analysis of the HFMs 
revealed a mesoporous pore size distribution, with an average pore diameter of 39.8 nm ± 3.9 
nm. HFM geometry was consistent both within and between batches, with average inner and 
outer diameters of 0.986 mm ± 0.042 mm and 1.29 mm ± 0.038 mm, respectively. 
 Material harvested from HFMs cultured with NIH/3T3 fibroblasts, rat skeletal muscle 
fibroblasts (RSMF), and astrocytes was translucent, showed no visual evidence of residual 
HFM, and exhibited a continuous filament geometry similar to the diameter and length of the 
HFMs in which they were cultured (Figure. 3). Fibers were amenable to handling and could be 
woven into a simple crosshatch pattern in a manner consistent with traditional fiber weaving 
techniques. HFMs cultured with NIH/3T3 cells for three weeks yielded just under one 
milligram (0.89 ± 0.2 mg/mm) of ECM fiber for every mm of HFM seeded. Although still 
capable of producing continuous fibers, both skeletal muscle fibroblasts and astrocyte cells 
yielded significantly less ECM fiber material (0.44± 0.08 and 0.41± 0.04 mg/mm respectively). 
ECM fiber yield was sensitive to culture duration. 3T3 cells exhibited a 4- fold increase in ECM 
yield for three weeks versus one week of culture (p = 0.0134). Corresponding increases in yield 





 Transverse and longitudinal sections of NIH/3T3 ECM fibers (7 μm thickness) revealed a 
porous yet interconnected network of eosin stained ECM (Figure. 4). ECM fibers exhibited 
open-cell pores distributed irregularly throughout the sections. Analysis of transverse sections 
indicated an average interior ECM fiber porosity of 32.7% ± 5.8%. SEM images of lyophilized 
NIH/3T3 ECM fibers revealed a dense surface skin with a rough filamentous texture that is 
consistent with the appearance of native tissue ECM. The surface skin also showed evidence of 
fibril alignment along the longitudinal axis of the ECM fiber. Residual HFM material was not 
observed. 
 ATR-FTIR spectra of NIH/3T3 ECM fibers revealed strong absorbance at 1650 cm−1 and 
1540 cm−1, consistent with the amide I and II absorbance bands characteristic of proteins 
(Figure 5)28. Comparison of the spectra of isolated ECM fibers to the spectra of cultured and 
uncultured polysulfone HFMs indicated that the characteristic polysulfone absorbance peaks 
(1580, 1480, 1236, and 1150 cm−1) were not present in the ECM fiber samples, suggesting 
effective dissolution of the polysulfone HFM via NMP incubation. 
 Mechanical testing of HFMs (Figure 6) yielded an average elastic modulus of 10.0 MPa ± 
1.82 MPa and an average ultimate strength of 0.717 MPa ± 0.124 MPa. Stress-strain curves for 
HFMs exhibited linear elastic regions followed by small plastic regions and sharp failure. 
HFMs stretched to an average of strain of 13% prior to failure. Stress-strain curves for 
decellularized NIH/3T3 ECM fibers consistently exhibited toe-in regions, typically extending 
out to 10%, followed by a near linear increase in stress until failure. No significant plastic 
region was observed. The average elastic modulus and ultimate strength for ECM fibers 




average, ECM fibers stretched 29% ± 18% in length before failure. The accumulated ECM 
fibers were notably less stiff and more extensible than the once present HFM scaffolds. 
 Isolated NIH/3T3 ECM fibers were strongly reactive to antibodies directed against 
fibronectin (Figure 7). Second harmonic generation imaging also indicated the presence of 
fibrillary collagen throughout the ECM fibers. MS/MS proteomic analysis identified an array of 
ECM structural components (Table 2), including collagen I, III, VI, XVIII, fibronectin, fibrillin 
1, fibulin 1 and 2, and prolargin. Several matricellular proteins were also present, including 
EFEMP 1 and 2, thrombospondin 1 and 2, tenascin, and periostin. A complement of 
proteoglycans was identified as well, including biglycan, decorin, glypican 1 and 6, and 
versican. Pre-decellularization samples were strongly reactive to phalloidin and DAPI staining, 
while post-decellularization samples exhibited no specific staining. The gross appearance and 
handling of ECM fibers was not significantly altered by decellularization, as fibers remained 
continuous and amenable to handling. When reseeded with cells, the NIH/3T3 ECM fibers 
supported the attachment and recultivation of NIH/3T3 fibroblasts. Calcein AM staining 
directed against NIH/3T3 cells indicated that viable cells were distributed densely across the 
surface of the cultured fibers, reaching confluency within 72 hours (Figure 8). EthD-1 staining 
indicated a negligible quantity of non-viable cells. No pre-culture treatments (e.g. incubation 
with fibronectin) were required for adhesion of cells to the ECM fibers. 
 All implanted animals tolerated the implantation surgery well and gained weight 
throughout the observation period at a rate (8±2 grams/week) that was not significantly different 
from un-implanted controls (9±2 grams/week). At 2 weeks post implantation, samples were 
well incorporated into the surrounding tissue and host cells had densely penetrated the material 




implants, nor a necrotic region within it. By 6 weeks post implantation, implant sites showed 
evidence of elevated cellularity, but it was sharply reduced when compared to 2 week samples, 
suggesting ongoing implant degradation. There was no evidence of local toxicity nor was there 
any evidence of multinuclear giant cell formation in regions surrounding the implants at either 
timepoint. 
D. Discussion 
 In this study, we have developed a process for extracting whole threads of ECM secreted 
by cells cultured in the lumina of sacrificial HFMs. Our findings suggest that this HFM culture 
approach is amenable toward the production of filaments of ECM from several cell types, and 
that these filaments have a composition and structure that may find utility for the repair of 
fibrous tissues in the form of a surgical mesh. The operating principle of the sacrificial HFM 
culture method is that ECM produced by cells cultured in the lumina of HFM’s can be captured 
and concentrated by preventing cross-membrane transport of ECM constituents. To our 
knowledge, this study represents the first time in literature that culture of cells in the lumen of 
HFMs has been leveraged for the production and extraction of ECM. Evapoporometry data 
indicate that the pores of the membranes fabricated in this study are substantially smaller than 
the hydrodynamic radii for ECM components such as collagen I (>80 nm at 37 °C)29, 30 or high 
molecular weight hyaluronan (103 nm for mW = 2000 kDa)31, indicating that these constituents 
are unlikely to diffuse across the membrane, driving ECM to accumulate in the lumina of the 
HFMs. Conversely, the small hydrodynamic radii of cell medium constituents such as bovine 
serum albumin (3.48 nm)32 suggests that they can diffuse across the membrane wall unimpeded. 
While an in-depth study of ECM bioseparation was beyond the scope of this investigation, the 




selective retention of desirable ECM constituents such as high molecular weight hyaluronan 
(anti-inflammatory) while permeating others (e.g., pro-inflammatory low mW hyaluronan)33 
 Incorporation of ECM components into a fiber geometry is not entirely without precedent. 
Alberti and Xu used sheets of decellularized tendon to form fiber-like collagen constructs34; 
another notable advance was made by Onoe et al, wherein hydrogels treated with individual 
ECM proteins were seeded with various cell lines to generate long fibers with encapsulated 
cells35; however, the scaffolding material, being composed of a hydrogel treated with individual 
ECM proteins, does not approximate the multimolecular nature of ECM. Past investigations 
have demonstrated that subtle aspects of ECM composition play an important role in tissue 
regeneration. For example, heparan sulfate proteoglycans (HSPGs) are known to be necessary 
for FGF-2 signaling which regulates angiogenesis and the proliferation of satellite cells during 
myogenesis36. Further, the combination of glycosaminoglycans and structural proteins in 
biomaterials have been shown to improve primary muscle cell proliferation, myoblast fusion, 
and skin regeneration, as well as bone formation in vivo37–40. The literature at large therefore 
suggests that the inclusion of an array of key ECM constituents in scaffolds bears clinical 
relevance for the regeneration of a range of tissues. 
 Our data suggest that the ECM fibers isolated in this study are bio-complex; 
immunoreaction of ECM fibers with antibodies for key ECM constituents, second-harmonic 
generation microscopy, and tandem mass spectrometry appear to demonstrate the 
multimolecular nature of this material. Several of the ECM constituents identified in ECM 
fibers are critical elements for the regeneration of a broad range of tissues including skeletal 
muscle, a target of interest for our group41. The fibril- forming collagens I and III found in ECM 




is an important component of the basement membrane surrounding skeletal muscle42. Biglycan 
and decorin, implicated in cutaneous wound healing and key regulators of collagen organization 
in skeletal muscle-were also identified43, 44. Further, some notable secreted factors were present 
in ECM fibers, including HDGF, IGF-II, and PEDF, playing various roles in liver, bone, and 
peripheral nerve regeneration45–48. While detergent-based decellularization techniques tend to 
remove various elements of ECM scaffolds, an array of alternative methods exist which may 
better preserve glycosaminoglycan and growth factor content49. 
 Delivery of therapeutic cells for wound-healing, especially progenitor cells, shows unique 
promise, as their inclusion into implants can promote angiogenesis50 and diminish the foreign 
body response to a biomaterial through the downregulation of pro-inflammatory cytokine 
expression51. This, however, presents challenges to scaffold design; the scaffold must obviously 
exhibit minimum cytotoxicity, but also have properties that serve to retain the desired 
phenotype of the carried cells, as the absence of cues provided in cell culture may cause them to 
lose desired characteristics in vivo. It has been observed that cells cultured on substrates coated 
with tissue-specific ECM better retain their differentiated phenotypes, and that progenitor cells 
exhibit improved proliferation and retention of differentiation potential on these materials52, 53. 
This suggests that scaffolds composed of whole ECM may find applicability as carriers of 
therapeutic cells. Although cytocompatibility was not examined with progenitor cells, the ECM 
fibers produced in this study contain key cell attachment proteins and were supportive of 
NIH/3T3 cell cultivation, with rapid proliferation leading to confluency in 72 hours and 
negligible cell death. When taken as a whole, the ECM fibers appear to have desirable cell 
adhesive properties that could be leveraged to deliver a range of attachment dependent cells. 




in vivo and in vitro biocompatibility testing results indicate that the solvent can be washed from 
the ECM samples prior to implantation. 
 One of the recognized limitations of first generation ECM fibers is their modest yield and 
strength when compared to both synthetic polymers and native tissue ECM. To address this 
shortcoming, next generation fabrication approaches could draw from the rich repertoire of cell 
culture techniques known to influence in vitro ECM production. Among these, media 
supplementation with cytokines possessing known ECM stimulatory properties would appear to 
be a logical first approach. HFM’s can be designed with pore diameters that allow the transport 
of cytokines including, HGF, VEGF, and CTGF into the lumen, while still trapping the larger 
structural proteins of interest. In addition to cytokines, the addition of crowding-inducing 
compounds such as dextran sulfate or Ficoll in culture medium has previously been exploited to 
increase in vitro ECM deposition and organization and may provide a unique synthetic 
approach toward enhancement of ECM fiber yield56, 57. Alternatively the cell itself could be 
manipulated to modulate ECM production. Recently developed CRISPR/Cas9 gene editing 
techniques58, 59 may provide a pathway for the production of “designer” cells with targeted 
ECM production capabilities. For example, the removal of collagen type I genes may create a 
cell with enhanced collagen type III production. Similar “knock in” gene editing techniques 
could be used to selectively increase ECM production60. 
 In addition to their use in woven implants, ECM fibers could potentially find utility as the 
print material in 3-D bio-printing systems61, 62. The most common type of printing method, 
fused deposition, utilizes long filaments to build up an object of interest. We could envision a 
system in which the synthetic fibers are replaced by ECM fibers, which are then used to print 




available with traditional 3-D printing systems, it may be possible to print using an assortment 
of ECM fibers synthesized using vascular, nerve, and cardiac cells. The data presented in this 
study demonstrate that ECM fibers are producible across several cell types, including 3T3 
fibroblasts, rat skeletal muscle fibroblasts, and astrocytes. While differences in ECM fiber 
composition between each of these cell types were not explored, it is known that the in-vitro 
production of ECM does vary by cell types. Variations in ECM production between cell types 
could be exploited to create a pallet ECM fibers with varying compositions. Using such a 
system, it may be possible to bio-print tissues and organs with heterogeneous structures and 
compositions (e.g. vascular fibers embedded within dermal fibers). A further benefit of this 
platform is that human cells could be leveraged for the production of allogeneic grafts while 
autologous implants could be produced by isolating and culturing the patient’s own cells. While 
impractical for the rapid treatment of acute injuries, patient specific implants may be applicable 
for the treatment of chronic injuries. 
E. Conclusions 
The results of this study suggest that: 
1. Hollow fiber membrane cell culture is applicable toward the production of continuous threads 
of ECM. 
2. ECM fibers are amenable to handling and can be assembled into multi-fiber meshes. 
3. Isolated ECM fibers exhibit a diverse complement of fibrous ECM proteins, proteoglycans, 
and matricellular factors. 
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Figure 1: Hollow Fiber Membrane Fabrication 
Hollow fiber membranes were fabricated using a custom-built dry-jet wet spinning system (A). 
Polymer and solvent solutions were extruded by pressurized N2 through an annulus and needle 
internal to a spinneret. Solutions exiting the spinneret (B: arrow) begin to form a nascent hollow 
fiber membrane by non-solvent induced phase separation via contact with the water bath. 
Following precipitation, membranes were collected on a motorized take-up wheel (C) at a rate 
of 2.2 meters per minute, producing 100 meters of membrane in 45 minutes. 
 
Figure 2: Membrane  Structure and Pore Size Distribution 
Transverse SEM micrographs (A and B) of representative HFF’s show a concentric asymmetric 
membrane with interior and exterior skin layers harboring finger-like pores. Evapoporometric 
determination of the membranes’ pore diameter distribution (mean = 39.8 nm ± 3.9 SD, n = 3) 
revealed a mesoporous distribution of pores with sizes large enough to permit nutrient transport, 
but small enough to trap large structural proteins within the HFM lumen. 
 
Figure 3: ECM Fiber Capture, Manipulation, and Yield 
Following one or three weeks in culture, cell seeded hollow fiber membranes were (A) 
dissolved in NMP and the accumulated ECM was collected (green). Cell derived material 
isolated following dissolution (B) was formed into a continuous filament that could be 
manipulated into a conceptual weave (C). ECM fibers were collected from all cells types tested. 
ECM  yield (D) was sensitive to both cell type and culture duration. Levels not connected by 
same letter are significantly different (p<0.05, ANOVA with post hoc Tukey’s test). 
 
Figure 4: ECM Fiber Structure 
Representative H&E stained images of transverse (A) and longitudinal (B) ECM fiber thin 
sections (thickness = 7 µm) reveals the porous yet interconnect network of accumulated ECM. 
SEM micrographs (C and D) of ECM fibers (50x and 1000x, respectively) illustrate the fibers 







Figure 5: ATR-FTIR Analysis 
ATR-FTIR spectra for (a) NIH/3T3-derived ECM fibers, (b) polysulfone HFMs cultured with 
NIH/3T3 cells for 3 weeks, and (c) uncultured naïve polysulfone HFM were captured using a 
Spectrum BX FTIR spectrometer with an ATR accessory and a scanning resolution of 8 cm-1. 
Isolated ECM fibers exhibit strong absorbance in the protein-indicative amide bands, with 
negligible absorbance for the bands characteristic of polysulfone. 
 
Figure 6: Membrane and ECM Fiber Tensile Properties  
Representative HFM  stress-strain curve (A), elastic modulus (B) and ultimate strength (C) 
values for mechanical tested (tensile) HFM samples (mean + SD, n = 3), with representative 
stress-strain curve (D), elastic modulus (E) and ultimate strength (F) for mechanically tested 
ECM fibers (mean + SD, n = 3). ECM fiber stress-strain curves were characterized by a toe in 
region followed by a near linear rise in stress until failure. 
 
Figure 7: ECM Fiber Immunofluorescence and Decellularization 
ECM fibers samples were immuno-stained to detect the presence of fibronectin (A), a key cell 
adhesive protein. Imaging via second--harmonic generation was utilized to detect the presence 
of fibrillar collagens, key structural proteins. ECM fibers were strongly reactive to both. 
Nucleus and actin staining of control (C and E) and decellularized ECM fibers (D and F) was 
used to examine process effectiveness. The SDS based decellularization process appeared to 
effectively remove cellular debris from ECM fibers without disrupting the continuity of the 
fibers. 
 
Figure 8: Biocompatibility 
Calcein AM cell viability staining of NIH/3T3 fibroblasts seeded and cultured on an isolated 
ECM fiber for 72 hours. Viable cells were attached to and densely distributed across the surface 
of the ECM fibers. Stained (H&E) thin sections collected from ECM implanted in Sprague 
Dawley rats at 2 (B) and 6 weeks (C). Increased cellularity observed within the dorsal 
subcutaneous implantation site at 2 weeks (*) is largely resolved by 6 weeks (n = 3/timepoint). 
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Engineered scaffolds derived from extracellular matrix (ECM) have driven significant interest in 
medicine for their potential in expediting wound closure and healing. Extraction of extracellular 
matrix from fibrogenic cell cultures in vitro has potential for generation of ECM from human- and 
potentially patient-specific cell lines, minimizing the presence of xenogeneic epitopes which has 
hindered the clinical success of some existing ECM products. A significant challenge in in vitro 
production of ECM suitable for implantation is that ECM production by cell culture is typically of 
relatively low yield. In this work, protocols are described for the production of ECM by cells 
cultured within sacrificial hollow fiber membrane scaffolds. Hollow fiber membranes are cultured 
with fibroblast cell lines in a conventional cell medium and dissolved after cell culture to yield 
continuous threads of ECM. The resulting ECM fibers produced by this method can be 
















Implantable surgical scaffolds are a fixture of wound repair, with over one million synthetic 
polymer meshes implanted worldwide each year for abdominal wall repair alone1. However, 
following implantation the synthetic materials polymers traditionally used in the fabrication of 
these scaffolds tend to provoke a foreign body response, resulting in inflammation deleterious to 
the function of the implant and scarring of tissue2. Further, as the predominant synthetic mesh 
materials (i.e., polypropylene) are not appreciably remodeled by the body, they are generally 
applicable to tissues where scarring can be tolerated, limiting their clinical usefulness toward the 
treatment of tissues with higher-order function such as muscle. While there are many surgical mesh 
products which have been applied with clinical success, recent manufacturer recalls of synthetic 
surgical meshes and complications from interspecies tissue implants highlight the importance of 
maximizing implant biocompatibility, prompting the FDA to tighten regulations on surgical mesh 
manufacturers3,4. Implantation of scaffolds derived from patients’ own tissues reduces this immune 
response, but can result in significant donor-site morbidity5. Extracellular matrix (ECM) scaffolds 
produced in vitro are a possible alternative, as decellularized ECM scaffolds exhibit excellent 
biocompatibility, particularly in the case of autologous ECM implants6.  
Because of the limited availability of patient tissue to harvest for autologous implantation 
and the risk of impeding function at the donor site, the ability to produce ECM scaffolds in vitro 
from the culture of human cell lines or, if possible, a patient’s own cells is an attractive alternative. 
The primary challenges in the manufacture of substantial amounts of ECM in vitro is the 
sequestration of these difficult-to-capture molecules. In previous work, we have demonstrated that 
ECM can be produced by culturing ECM-secreting fibroblasts in sacrificial polymeric foams that 




implantation7,8,9,10. As ECM produced in foams tend to adopt the internal architecture of the foams, 
hollow fiber membranes (HFMs) were explored as a sacrificial scaffold for production of threads 
of ECM. Described herein are methods tasked for lab scale manufacturing of cell culture quality 
hollow fiber membranes and the extraction of bulk extracellular matrix fibers from the same 
following a period of fibroblast culture. This static culture approach is readily adoptable by 
laboratories containing standard mammalian cell culture equipment. ECM produced by this 
approach could be applied toward a variety of clinical applications. 
B. Protocol 
1. Production of Extracellular Matrix Using Sacrificial Hollow Fiber Membranes 
CAUTION: N-methyl-2-pyrrolidone is an irritating solvent and reproductive toxicant. Exposure 
to NMP may cause irritation to the skin, eyes, nose, and throat. Solvent-resistant personal 
protective equipment should be used when handling NMP. Use of NMP should be performed 
within a fume hood. 
1.1. Preparation of polysulfone polymer solution for hollow fiber membranes 
1.1.1. Weigh 70 g of polysulfone pellets (molecular weight of 35 kD) in a weigh boat using an 
analytical balance. 
1.1.2. Transfer 314 mL (323.3 g) of N-methyl-2-pyrrolidone (NMP) to a clean borosilicate flask. 
 
1.1.3. Place a stir bar in the flask with NMP and place flask onto stirrer. Set the stirrer to a 
moderate rate of rotation.  
1.1.4. Use a dry funnel to slowly insert the prepared 70 g of polysulfone into the flask with NMP.  





1.2. Setting concentricity and cleaning of the hollow fiber membrane spinneret 
Note: Spinnerets are commercially available; correct spinneret dimensions are critical to 
successful membrane fabrication and are listed in the Table of Materials. Handle the spinneret 
very gently, as the spinneret needle is particularly fragile. 
1.2.1. Use a screwdriver or drill with an appropriate screwdriver bit to carefully disassemble the 
spinneret. 
1.2.2. Gently flow acetone through the inlet and outlet of the spinneret, collecting any acetone 
and residual polymer in a glass beaker for disposal. 
1.2.3. Secure the upper body of the spinneret with the needle facing upward in a table vise.  
1.2.4. Place the outlet (bottom) body of the spinneret onto the upper body.  
1.2.5. Move the outlet body of the spinneret laterally while holding the upper body fixed on the 
vise until the spinneret needle is directly in the center of the outlet body.  
1.2.6. Carefully and slowly reinsert the screws connecting the two bodies of the spinneret while 
ensuring that the needle visible at the spinneret outlet remains centered. 
1.3. Fabrication of polysulfone hollow fiber membranes 
1.3.1. Prepare a “bore solution” containing 45 mL of N-methyl-2-pyrrolidone and 255 mL of 
deionized water, forming a 15% mixture of NMP with deionized water.  
1.3.2. Mount a concentric hollow fiber membrane spinneret 8 cm above the surface of a room-
temperature tap water bath.  
1.3.3. Connect the polymer inlet of the spinneret and the bore inlet of the spinneret to two 
separate steel pressure vessels having an inner volume of at least 350 mL. Both vessels must 
have check valves at their outlets.  




1.3.5. Use a funnel to insert the prepared dope solution (~315 mL) into the pressure vessel 
connected to the polymer inlet of the spinneret. Ensure that the top of the vessel is tightly sealed. 
1.3.6. Use a funnel to insert the prepared bore solution (300 mL) into the pressure vessel 
connected to the bore inlet of the spinneret. Ensure that the top of the vessel is tightly sealed. 
1.3.7. Open the check valve for the bore vessel first, then the polymer vessel second. If the 
spinneret is sufficiently clean, the bore solution will begin to stream out of the spinneret outlet. 
1.3.8. Pressurize both vessels to 1 PSI. Visually confirm that both polymer and bore solutions are 
exiting the spinneret, with a continuous white filament precipitating as the combined streams 
contact the water bath. 
1.3.9. Use long forceps to guide the nascent fiber under the rollers in the center of the bath, and 
then wind the nascent fiber around a rotating wheel connected to a motor.  
1.3.10. Set the take-up wheel and motor to rotate at a rate of approximately two meters per 
minute. 
1.3.11. Make minor adjustments to the regulators or take-up wheel speed as needed until a 
steady-state flow is achieved. The nascent fiber should form a 90° angle with the surface of the 
water bath.  
1.3.12. Close the N2 cylinder regulators and pressure vessel check valves and disengage the take-
up wheel motor after all polymer and bore solution has been extruded from the vessels. 
1.3.13. Remove the prepared hollow fiber membranes and place them into a deionized water bath 
for three days, exchanging deionized water once per day to remove residual solvent. 
1.3.14. Sterilize the hollow fiber membranes by autoclaving them at 121 °C for 30 minutes or by 





1.4. Cell seeding of hollow fiber membranes 
Note: All cell culture procedures should be performed within a biosafety cabinet.  
1.4.1. Treat the hollow fiber membranes with a 20 &#181;g/mL solution of bovine plasma 
fibronectin in PBS (pH = 7.4) to promote cell attachment. 
1.4.1.1. Weigh 1 mg of powdered bovine plasma fibronectin in a weigh boat and dissolve it in 1 
mL of sterile PBS (pH = 7.4) in a sterile 1.5 mL microcentrifuge tube. 
1.4.1.2. Incubate the 1 mg/mL bovine plasma fibronectin solution in the incubator for 30 
minutes. Add the solution to 49 mL of sterile PBS in a sterile 50 mL conical centrifuge tube. 
1.4.1.3. Incubate the fibers in the prepared 50 mL of bovine plasma fibronectin in an incubator at 
37 °C with 5% CO2 for 1 hour. Recollect the fibronectin solution for later use and store in a 
sterile 50 mL conical centrifuge tube at 4 °C. 
1.4.2. Use sterile microscissors to cut the fibers to desired length (&lt;6 cm). 
1.4.3. Seed fibroblast cells directly into the lumina of the hollow fiber membranes at a seeding 
density of 100,000 cells per fiber using a 21-gauge needle with 1 mL syringe. 
Note: A practicable target for preparing the cell-suspension for loading in the syringe is a 
suspension density of 100,000 cells for every 30 microliters of medium. 
1.4.4. Place six seeded fibers into a 6 cm diameter Petri dish. Allow the seeded fibers to incubate 
at 37 °C with 5% CO2 for five minutes. 
1.4.5. Remove the seeded fibers from incubation and culture them for up to 3 weeks in 
DMEM/F-12 containing final concentrations of 50 &#181;g/mL L-ascorbic acid and 150 
&#181;g/mL L-ascorbic acid 2-phosphate (freshly prepared and sterile filtered), 5 ng/mL TGF-
ß;1 (from sterile filtered aliquots stored at -20 °C), and 1% penicillin-streptomycin in a 6 cm 




1.5. Extraction of extracellular matrix from cultured hollow fiber membranes 
1.5.1. Place cultured fibers into individual scintillation vial using forceps. 
1.5.2. Place up to 5 mL of NMP into each vial using a glass pipette. 
1.5.3. Immerse the hollow fibers in NMP, performing a total of three exchanges of NMP. Slowly 
aspirate the old NMP using a 1 mL pipette to prevent tearing of extracted ECM. 
Note: When adding fresh NMP, it is helpful to tilt the vial and allow the NMP run down the 
sides, otherwise the remaining ECM scaffold is subjected to shear which may cause tearing. 
1.5.4. Remove NMP and rinsed the resulting ECM thread 3 times in deionized water. 
1.5.5. Cut a 1/32-inch thick sheet of silicone rubber to a length of 3 inches, width of 1 inch and 
cut an 8 mm by 4 mm rectangular mold in the center of the length of rubber. 
1.5.6. Place the prepared piece of rubber onto a standard 3-inch by 1-inch microscopy slide and 
autoclave at 121 °C for 30 minutes. 
1.5.7. Lay each ECM fiber side by side in the 8 mm by 4 mm silicone mold until there is no 
visible open space. 
1.5.8. Place the mold into a 50 mL conical centrifuge tube and freeze at -80°C until completely 
frozen. 
1.5.9. Lyophilize frozen ECM mesh overnight or until completely dry. Store the mesh at 4°C 
until ready for decellularization. 
2. Decellularization of Extracellular Matrix 
2.1. Prepare a solution of 1% (w/w%) sodium dodecyl sulfate (SDS) in deionized water. 
2.2. Incubate extracted extracellular matrix in the mold in 1% SDS for 24 hours at room 




2.3. Rinse extracted extracellular matrix three times in sterile phosphate-buffered saline (PBS) 
with gentle agitation, using 3 mL of PBS per rinse. 
Note: Rinses should be performed gently to minimize tearing of prepared scaffolds. 
2.4. Prepare 1 L of DNAse/RNAse digestion buffer.  
Note: DNAse/RNAse digestion buffer may be stored for several months at 4°C. 
2.4.1. Weigh 1.54 g of Tris HCl, 308 mg of MgCl2, and 56 mg of CaCl2 in separate weigh boats. 
2.4.2. Combine Tris HCl, MgCl2, and CaCl2 with 1 L of deionized water in a large flask with a 
stir bar and stir until all components are dissolved. 
2.4.3. Sterile filter the digestion buffer with a 0.22 &#181;m filter into a sterile 1 L borosilicate 
bottle and store at 4°C. 
2.5. Prepare 5 mL of DNAse/RNAse digestion solution.  
Note: Digestion solution should be used within 24 hours of preparation.  
2.5.1. Weigh 0.125 mg (50 kU) of DNAse I in a weigh boat and add to 5 mL of digestion buffer. 
2.5.2. Add 75 &#181;L of RNAse A stock solution to the digestion buffer. 
2.6. Add 32 &#181;L of the digestion solution to each prepared mold and incubate at 4°C for 6 
hours. 
2.7. Aspirate the digestion solution and rinse three times in sterile PBS. 
2.8. Aspirate the PBS and incubate scaffolds overnight in 10% penicillin-streptomycin in PBS at 
4°C.  
2.9. Aspirate the penicillin-streptomycin and rinse scaffolds three times in sterile PBS. 
2.10. Place the mold into a 50 mL conical centrifuge tube and freeze at -80°C. 




2.12. Transfer the lyophilized scaffolds within a biosafety hood to a sterile container at 4°C 
pending use. 
C. Results 
Successful production of extracellular matrix from sacrificial scaffolds is contingent on 
appropriate scaffold fabrication, cell culture, and solvent rinse procedures. Fabrication of the 
hollow fiber membranes is performed using a dry-jet wet-spinning system assembled from 
commercially available components (Figure 1) which uses extrusion of polymer solution 
through the annulus of a commercially available steel spinneret (inner diameter = 0.8 mm, outer 
diameter = 1.6 mm) to generate a nascent tube of polymer solution which precipitates into a 
hollow fiber membrane upon contact with a water bath.  
An example process for ECM extraction from HFMs is illustrated in Figure 2. Figure 
3A shows a transverse cross-section of polysulfone HFMs fabricated under this protocol, 
exhibiting outer and inner layers of finger-like pores characteristic of an asymmetric membrane. 
In this protocol, cells are seeded specifically in the inner lumen of the membrane and cultured in 
6 cm diameter Petri dishes (Figure 3B), with cells tending to proliferate on all surfaces of the 
membrane. Cultured membranes can then be subjected to batch NMP and deionized water 
rinsing in standard glass scintillation vials (Figure 3C), producing translucent threads of ECM 
(Figure 3D). ECM-producing cells remain viable inside HFMs throughout the 3-week period of 
culture (Figure 4). 
HFMs cultured for three weeks with primary rat skeletal muscle fibroblasts (RSMF) were 
dissolved via three exchanges of N-methyl-2-pyrrolidone, after which they were rinsed three 
times in deionized water. The extracted matrix, normally being translucent in appearance when 




rinsing due to the presence of residual polymer. It should also be noted that the ECM remaining 
after dissolution of the membrane is somewhat fragile, requiring care in handling with fine 
forceps. ECM fibers assembled into meshes and then lyophilized exhibit an off-white color and 
fibrous appearance with a gross longitudinal alignment (Figure 5B). 
D. Discussion 
The processes described enable the production of bulk ECM biomaterials in vitro using 
hollow fiber membranes cast by a dry-jet wet spinning system allowing for inexpensive bulk 
production of membranes as well as standard cell culture equipment. While the membranes 
fabricated in this protocol are intended for use in cell culture, the system described can also be 
adapted for the production of membranes for separation purposes, with pore size distribution and 
hollow fiber dimensions tunable by varying spinneret dimensions, polymer used, dope and bore 
flow rate, take-up speed, and environmental conditions.13 Though the protocol detailed employs 
hollow fiber membranes, in principle any dissolvable cell culture scaffold with appropriate 
transport properties such as open cell foams could be used, as demonstrated in previous work7-9. 
This general approach appears useful for the production of ECM scaffolds by sacrificial 
scaffolds which can more faithfully mimic the internal architecture of tissues. Implants produced 
by this protocol in particular exhibit a gross alignment (Figure 5B), which may be of particular 
benefit toward the reconstruction of highly aligned tissues such as tendons, ligaments and 
skeletal muscle.  
Regular exchange of medium and, in particular, supplementation of medium with 
ascorbic acid and TGF- ß; is crucial to production of ECM, as ascorbic acid is an essential 
enzyme in collagen biosynthesis, and TGF- ß; induces the synthesis of several ECM proteins10. 




polymer will remain in the extracted ECM, appearing as a white film during water rinses. Care 
must be taken to not overly agitate ECM during membrane dissolution, as it is relatively fragile. 
Collected ECM scaffolds intended for implantation must be subjected to a decellularization step 
as described to remove xenogeneic epitopes to minimize a potential host foreign body response. 
 The significance of this technique lies in its production of a biocomplex scaffold of whole 
extracellular matrix which can be remodeled by the body’s own wound-healing processes. By 
using this approach to produce ECM from cells specific to a target species, it may be possible to 
minimize the foreign body response which hinders the clinical effectiveness of this class of 
biomaterials; by using cells specific to an individual, the foreign body response may be lessened 
further. This approach also allows for the production of ECM targeted toward particular tissues, 
with recent reports suggesting that tissue-specific ECM may be particularly effective in certain 
applications12. As this protocol allows for production of ECM across various cell lines, implants 
combining ECM from several cell types (e.g. muscle, nervous, endothelial) could be used to 
tailor implants to more faithfully approximate the structure and chemical complexity of target 
tissues. While the ECM meshes presented here were originally intended as scaffolds for wound 
repair, they may also have use as platforms for investigations into cell-ECM interactions, 
durotaxis, and biosensing. In particular, this approach lends the investigator the ability to 
produce ECM from specific cell types of interest which may allow for new insights into the 
biological significance of tissue-specific ECM structure, composition and function.  
Potential improvements to the ECM production techniques presented here could include 
scale-up via the use of dynamic and pre-conditioning bioreactors as well as exploration of 
alternative sacrificial scaffold materials and architectures. In particular, transition to a solventless 




composed of materials which are degradable by enzymes, such as regenerated cellulose, may 
allow for solventless ECM extraction14. While the tensile strength of these materials is below 
those of synthetic materials, there exist several avenues for improvement of these scaffolds, 
including exploration of various culture conditions, media formulations, and sacrificial scaffold 
geometries. Recent genetic engineering advances could be leveraged to produce pro-fibrotic cell 
lines, which in combination with platforms for ECM capture could enable the production of 
scaffolds satisfying clinical demands. Further, existing dynamic culture systems such as 
continuous flow-loop hollow fiber membrane bioreactors facilitate high rates of nutrient 
exchange conducive to greater and more rapid ECM production, and may be of particular interest 
in leveraging this technique for production of larger quantities of ECM for biological research 
and clinical use. 
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Table 1: Table of Specific Materials 
 
Material Supplier Catalog Number Comments 
1/32 inch thick silicone 
rubber 
Grainger B01LXJULOM  
20 mL Scintillation Vials VWR 66022-004 With attached white urea cap and cork foil liner 
3 inch by 1 inch microscopy 
slides 
VWR 75799-268  
4 °C refrigerator Thermo Fisher FRGG2304D Any commercial 4C refrigerator will suffice. 
50 mL conical tubes VWR 21008-178  
6-well cell culture plates VWR 10062-892 Alternative brands may be used 
Acetone VWR E646 Alternative brands may be used 
Bore vessel McMaster-Carr 89785K867 6 ft 316 steel tubing 
Bovine Plasma Fibronectin Thermo Fisher 33010018 Comes as 1 mg of lyophilized protein 
CaCl2 VWR/Amresco 97062-590  
Cell Culture Incubator w/ 
CO2 
  Any appropriate CO2-supplied mammalian cell 
incubator will suffice. 
Disposable Serological Pipets VWR 14673-208 Alternative brands may be used 
DMEM/F-12, HEPES Thermo Fisher 11330032 Warm in water bath at 37°C for 30 minutes prior to use 
DNase I Sigma-Aldrich DN25-10MG  
Dope vessel McMaster-Carr 89785K867 6 ft 316 steel tubing 
Ethanol VWR BDH1160 Dilute to 70% for sterilization 
Fetal Bovine Serum, 
qualified, US origin - Gibco 
Thermo Fisher 26140079 Mix with growth media at 10% concentration (50mL in 
500mL media) 
Four 1/4-inch to 1" reducing 
unions 








Table 1: Table of Specific Materials 
Material Supplier Catalog Number Comments 
Freeze-dryer/lyophilizer Labconco  117 (A65312906) Any lyophilizer will suffice. 
Hexagonal Antistatic 
Polystyrene Weighing Dishes 
VWR 89106-752 Any weigh boat will suffice 
Hollow fiber membrane 
immersion bath 
  34L polypropylene tubs may be used or large bath 
containers can be fabricated from welded steel sheets 





Made to order. Inner diameter = 0.8 mm, outer diameter 
= 1.6 mm 
Hot plate/stirrer VWR 97042-634  
Human TGF-β1 PeproTech 100-21  
L-Ascorbic acid Sigma-Aldrich A4544-25G  
L-Ascorbic acid 2-phosphate Sigma-Aldrich A8960-5G  
L-glutamine (200 mM) - 
Gibco 
Thermo Fisher 25030081 Mix with growth media at 1% concentration (5mL in 
500mL media) 
MgCl2 VWR/Alfa Aesar AA12315-A1  
Minus 80 Freezer Thermo Fisher UXF40086A Any commercial -80C freezer will suffice. 
N2 gas cylinders (two)    
NIH/3T3 cells ATCC CRL-1658 Alternative fibrogenic cell lines may be used. 







Table 1: Table of Specific Materials 
Material Supplier Catalog Number Comments 
Penicillin/Streptomycin 
Solution 
Thermo Fisher 15140122 Mix with growth media at 0.1% concentration (0.5 mL 
in 500mL media) 
Polysulfone Sigma-Aldrich 428302 Any polysulfone with an average Mw of 35,000 daltons 
may be used 
Portable Pipet-Aid Pipetting 
Device - Drummond 
VWR 53498-103 Alternative brands may be used 
PTFE tubing (1/4-inch inner 
diameter) 
McMaster-Carr 52315K24 Alternative brands may be used. 
Rat skeletal muscle 
fibroblasts 
  Independently isolated from rat skeletal muscle. 
Alternative fibrogenic cell lines may be used. 
RNase A Sigma-Aldrich R4642  
Silicone sheet McMaster-Carr 1460N28  
Take-up motor Greartisan B071GTTSV3 200 RPM DC Motor 
Tris HCl VWR/Amresco 97063-756  
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Figure 1: Illustrated process flow for casting hollow fiber membranes 
Hollow fiber membranes are manufactured using the ubiquitous non-solvent induced phase 
separation method (NIPS) using a system prepared from commercially available components listed 
in the table of specific materials. Polysulfone in NMP (17.8 w/w%) and NMP bore solutions (15 
w/w% NMP in water) are extruded from separate stainless steel vessels by pressurized N2 into a 
spinneret, generating a nascent hollow fiber membrane at the spinneret outlet which fully 
precipitates upon contact with the tap water precipitation bath. Nascent hollow fiber is manually 
guided under and over guides and allowed to collect on a rotating motorized take-up wheel at a 
rate of 2.3 meters per minute. 
 
Figure 2: Illustrated production of ECM from cultured hollow fiber membranes 
Hollow fiber membranes are seeded with fibroblasts and cultured for three weeks, followed by 
exchange of NMP 3x and exchange of deionized water 3x. 
  
Figure 3: Culture and extraction of ECM 
Asymmetric mesoporous hollow fiber membranes (A) were cultured for three weeks with RSMF 
cells in DMEM/F-12 with supplemented ascorbic acid and TGF-ß; (B). Cultured hollow fibers (C, 
D top) were dissolved via 3 exchanges in n-methyl-2-pyrrolidone then rinsed three times in 
deionized water, resulting in continuous threads of ECM (D, bottom). High magnification scanning 
electron microscopy micrograph of the ECM fiber surface (E). 
 
Figure 4: Cell viability on hollow fiber membranes 
Representative hollow fiber membranes cultured with RSMF cells for three weeks were 
longitudinally sectioned using a fine razor to reveal the luminal surface of the HFMs and subjected 
to live-dead staining with Calcein AM and EthD-1. Viability staining revealed a confluent layer 









Figure 5: Assembly of ECM implant 
Individual extracellular matrix threads (n = 30) derived from culture of RSMF cells were placed 
lengthwise into a silicone mold (A) and decellularized by 1% SDS followed by treatment with 
DNAse I, RNAse A, and penicillin-streptomycin. Decellularized ECM was then lyophilized, 
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Evapoporometry is a promising emerging method of pore diameter characterization with particular 
applicability toward characterization of mesoporous materials. The evapoporometric approach is 
notable for requiring relatively inexpensive and ubiquitous laboratory equipment relative to other 
pore characterization methods; however, to date the method has largely been relegated to groups 
dedicated to membrane characterization due to the nontrivial data analysis involved. In an effort 
to extend the use of this promising method beyond membrane specialists, we demonstrate a free 
open-source software aid for standardizing evapoporometry data analysis and assess its 
applicability for pore size of macroreticular ion exchange resins as well as estimation of surface 































The performance of porous materials used in separations processes is dictated primarily by 
their pore size distributions, making accurate characterization of pore size a critical aspect of the 
manufacturing process.1 In particular, mesoporous materials have broad application in industry as 
ultrafiltration membranes, catalysts, adsorbents, and drug carriers, where consistent performance 
requires tight control of pore size distribution, porosity, and surface area.2,3 A variety of techniques 
exist to characterize pore diameter, by direct methods –such as electron microscopy- or indirect 
such as mercury porosimetry.4 However, image analysis of pore size is performed on very small 
portions of the sample which may not be truly representative of the whole, while methods based 
on liquid displacement or gas adsorption often require rather expensive equipment and significant 
technical expertise on the part of the investigator. Further, methods such as mercury porosimetry 
require application of high pressures for detection of small pores which can affect the structure of 
the sample during measurement.5  
Evapoporometry (EP) is a relatively new method for indirect determination of pore 
diameter distribution based on the Kelvin equation, which relates vapor pressure to the curvature 
of liquid-gas interfaces within liquid-filled pores.6 Unlike gas adsorption/desorption or 
permporometry which characterize capillary condensation within pores7, evapoporometry relies 
on the measurement of the isothermal evaporation of a fluid from filled pores of a sample contained 
within a cylindrical test cell, with evacuation of liquid from larger pores preceding that of smaller 
pores due to increasing vapor pressure depression as pore size decreases. Krantz et al developed a 
mass transfer model demonstrating that the Kelvin equation can be rearranged to calculate pore 













Where y is the surface tension of the liquid within the pores, V is the vapor molar volume, 
R is the universal gas constant, T is absolute temperature, 𝑊𝐴0 is the evaporation rate of liquid 
from pores, and 𝑊𝐴0
°  is the evaporation rate of the fluid layer initially present above the sample. 
Fisher and Israelachvili found the Kelvin equation to be valid for menisci with a mean radius of 
curvature > 4 nm10, a finding later validated by Mitropoulos11. While the evaporating liquid most 
used in evapoporometry studies has been 2-propanol, the use of fluids with a higher surface tension 
and liquid molar volume have been found to allow for characterization of pore diameters up to 365 
nm.9 Unique to evapoporometry is the capability to evaluate the pore size distribution of samples 
across a range of fluids without the application of pressure, enabling the investigator to predict the 
separation properties of the sample in different liquid media. 
 Despite the promising agreement of evapoporometry-measured pore diameter distributions 
with competing methods, evapoporometry has thus far largely been applied to ideal well-
characterized samples such as commercial asymmetric Anopore membranes6,9, having regular pore 
and support structures allowing for a correction of evaporative mass-loss data necessary for highly 
asymmetric membranes.12,13 In contrast, the irregular substructure14 of solvent-cast asymmetric 
membranes precludes this asymmetry correction, making the method most appropriate as a tool 
for detecting relative changes in pore diameter distribution, as in the case of fouled asymmetric 
membranes.15  
In this work, we present an open-source standalone Python application for data analysis 




size distributions of asymmetric anodisc membranes macroreticular ion exchange resins, 
ubiquitous in water softening, purification, and catalysis.16,17. It is anticipated that the availability 
of a software platform for EP analysis will encourage the adoption of this useful adjunct to gold-
standard pore measuring techniques, and that its application toward nonclassical porous materials 
may yield fruitful insights for studies outside of the field of membrane research.  
Methods 
Evapoporometry 
An EP apparatus comprising a custom-fabricated PTFE test cell, analytical balance, and 
laptop interfaced to the balance by RS232-USB was assembled as described previously (Figure 
1).8 Samples were immersed in an evaporating fluid for 2 hours, then sealed into the test cell with 
a liberal application of vacuum grease on the periphery of the test cell to ensure one-dimensional 
mass transfer, with several drops of fluid added above the sample to produce a free-standing layer. 
2-propanol was selected as the evaporating fluid due to its nonwetting properties as well as its use 
in previous EP publications. Activated carbon was placed in scintillation vials surrounding the 
weighing plate as a desiccant to minimize the retention of volatile fluid in atmosphere. An XS105 
balance (Mettler Toledo; Greifensee, Switzerland) with a resolution of 10 µg was used to monitor 
evaporative mass loss over time under stable ambient temperature. 
Scanning Electron Microscopy 
 Visualization of sample surface morphology was achieved through direct use of a Nova 
Nanolab 200 following sputter-coating with gold-palladium before and after immersion for 2 







An open-source standalone program (Evapore) with a graphic user interface was 
developed in Python 3.7 to automate evapoporometry data analysis in order to minimize user 
error and ensure reproducibility. With source code and executable files available at 
github.com/RobertsEng/Evapore, the program proceeds as follows: 
1. The user is prompted by a dialog to load a headerless .XLSX file with the first column 
containing evaporative mass loss data for a test cell containing a fluid-saturated sample and 
an additional small layer of fluid overlying the sample.  
2. The user is prompted to input parameters related to the acquisition of gravimetric data for 
a layer of volatile fluid evaporating from an otherwise empty test cell, including the fluid 
used, absolute temperature, and time interval between acquisition of mass measurements. 
3. The mass column is subjected to a moving average (i = 20) to minimize the effect of noise 
on the calculated pore diameter distribution. 
4. The evaporation rate (g/s) is calculated from the slope of a mass versus time array.  
5. An interactive plot of evaporation rate versus time is rendered to the user, prompting them 
to select the initial x-axis values at which the period of constant evaporation occurs (WA0), 
corresponding to evaporation of the layer of fluid overlying the sample. The evaporation 
rates are converted to mol/s via division by the molecular weight of the fluid used. An 
average evaporation rate (WA0) and standard deviation for this period are then calculated. 
6. WA0 is used to determine the start point at which evaporation of fluid from the pores of the 
sample begins, corresponding to the first point on the graph at which WA < WA - 3σ. A 
horizontal line with height equal to this evaporation value is overlaid on the graph to guide 




7. The pore diameter corresponding to each instantaneous evaporation rate is computed using 
equation 2. 
8. Instantaneously measured pore diameters are grouped into bins with a width of 5 nm. The 
percentage of pore-evaporated mass for each bin is used to determine an average pore size 
by the Bachmann-Anderson-Gurvitsch rule. The user is prompted to save pore diameter 
data in .CSV format and an interactive graph of pore size distribution is rendered. 
Surface area of samples was assessed using the Bachmann-Anderson-Gurvitsch rule relating 
total pore volume to surface area, generally applied to materials with cylindrical, rigid, and well-
defined pores18-22: 
Equation 2 
D = 4V/S 
Where D is mean pore diameter, V is specific pore volume (m3/g), and S is specific surface 
area in m2/g. Mean EP pore diameter is substituted for D and the liquid volume of fluid evaporated 
during the pore draining period is substituted for V, allowing for calculation of specific surface 
area. Here, a specific volume derived from the density of the EP fluid used and mass lost during 
pore draining are substituted for V as an analog for specific pore volume.  
N2 Adsorption-Desorption 
Comparison of evapoporometry surface area measurements for Amberlyst-15 ion 
exchange resin was enabled by analysis of the resin in an Autosorb iQ automated gas sorption 
analyzer and data processing in ASiqwin software (Quantachrome). Samples were degassed at 100 







All statistical analysis was performed in Graphpad Prism v8.0.1 (Graphpad Software, San 
Diego). ANOVA with post-hoc Tukey’s test was used for all significance testing between groups 
(α = 0.05). Quantitative data are presented as mean ± standard deviation. 
Results 
 Scanning electron microscopy of anodisc membranes revealed highly ordered and dense 
pore structures for Anodisc membranes consistent with literature (Figure 3A) with an irregular 
and scattered pore structure for Amberlyst 15 ion exchange resin beads. Imaging of membranes 
and ion exchange resin following a 2-hour immersion in 2-propanol resulted in no evident 
changes to surface morphology. 
 Evapoporometric analysis of pore diameter for Anodisc 13, Amberlyst 15, and Anodisc 
47 samples yielded mean pore diameters of 24.9 ± 2.7 nm, 30.1 ± 3.0 nm, and 108 ± 1.1 nm, 
respectively (Figure 4A). Linear regression analysis of evapoporometric pore determination 
against nominal manufacturer-reported mean N2 adsorption-assessed pore diameter revealed a 
strong agreement (R2 = 99.37) and significantly non-zero slope (p < 0.0001) (Figure 4B). 
Representative pore diameter distributions for ANO-13, AMB-15, and ANO-47 ranged from the 
5-35 nm, 10-85 nm, and 5-300 nm bins, respectively. One-way ANOVA indicated significant 
differences within the diameter dataset (p <0.0001), with a post-hoc Tukey’s test indicating 
significant differences in diameter across ANO-13 versus ANO-47 (p < 0.0001) and AMB-15 
versus ANO-47 (p<0.0001). 
 Estimation of surface area by application of the Bachmann-Anderson-Gurvitsch rule for 
Anodisc 13, Amberlyst 15, and Anodisc 47 samples indicated approximate specific surface areas 




ANOVA indicated significant differences across the dataset (p = 0.0002), with post-hoc Tukey’s 
test indicating significant differences across all comparisons (p = 0.0131 for ANO-13 v AMB-
15, p = 0.0001 for ANO-13 vs ANO-47, and p = 0.0025 for AMB-15 v ANO-47). Measurement 
of Amberlyst-15 surface area by Brunauer–Emmett–Teller analysis of N2 adsorption-desorption 
indicated a surface area of 42.5 m2/g, identical to widely reported BET analysis of this material23, 
suggesting an overestimation of specific surface area by evapoporometry.  
Discussion 
 In this work we have evaluated the accuracy and precision of a standalone software 
application in analysis of Evapoporometry data for pore diameter distribution and surface area 
characterization for porous materials, including an ion exchange resin with a macroscale 
geometry substantially different from synthetic membranes analyzed in previous reports. While 
evapoporometry exhibits the advantages of limited equipment expense and straightforward 
experimental protocol, the data analysis involves a series of nontrivial data analysis steps 
including graphical analysis which leads to variation in final results between individual 
investigators. While an element of graphical analysis still exists in Evapore data processing in 
terms of the selection of the initial steady-state region of evaporation, the relative standardization 
of the process and automation of remaining steps minimizes between-user variation and enables 
rapid reanalysis.  
 While previous reports have investigated evapoporometry as a general method of pore 
diameter determination in the context of idealized alumina membranes there is substantial 
interdisciplinary interest in the determination of pore diameter distribution for more irregular 
materials such as nonsolvent-induced phase separation-cast membranes, macroporous ion 




can be used to predict properties ranging from gas diffusion to soil productivity24 (with the 
advantage that such samples can be analyzed by natural evaporation of water). We demonstrate 
that a semi-automated software-based analysis allows for fine determination of pore size for 
mesoporous materials, but notably with a lesser variation in comparison to previous reports for 
membranes of identical nominal pore size. It is additionally shown that evapoporometry 
faithfully reproduces the nominal mean pore diameter for Amberlyst 15, a macroporous ion 
exchange resin, with  
 We further demonstrate that while expected trends in surface area between different 
samples are reflected in relative terms in the evapoporometric determination of surface area via 
the Gurvitsch-rule, evapoporometry appears to substantially overestimate surface area compared 
to BET, indicating at present that the method appears unsuitable for determination of absolute 
surface area. Finer exploration of mathematical models applicable to EP may yield insights to 
reduce discrepancies between EP and gold-standard methods. 
Combination of this software-aided approach with open-source data acquisition 
technology is anticipated to reduce the financial, time, and personnel costs of pore size analysis 
and reduce the barrier of entry for investigators interested in mesoporous pore size and surface 
area properties but for whom existing methods are cost-prohibitive or otherwise inappropriate. 
The Evapore software tool developed in this tool is publicly available in both original source and 
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Figure 1: Illustrated evapoporometry workflow 
Samples were immersed in volatile fluid (2-propanol) for two hours to ensure complete 
saturation and pore filling, then secured to the base of a custom-fabricated PTFE test cell (ID = 
35 mm). A small amount of volatile fluid (<500 µL) was further added to the bottom of the test 
cell overlying the sample to produce a standing layer of fluid. Evaporative mass loss from the 
test cell is then monitored at stable ambient temperature (25 °C) using an analytical balance with 
a resolution of 10 µg. Raw mass and acquisition time data were input into a standalone python 
application to yield mean pore diameter, pore diameter distribution, and estimated surface area. 
 
Figure 2: Standardization of data processing in Python enables rapid and facile 
 
interpretation of evapoporometry mass loss data 
 
A standalone windows-executable Python application with graphic user interface (Evapore) was 
developed for evapoporometry data analysis wherein the user is prompted to (a) specify the 
evaporating fluid used, the constant temperature at which the mass loss experiment was 
conducted, as well as the data acquisition interval from the analytical balance used. The user 
loads a headerless .XLSX file containing mass data in the first column, after which Evapore 
renders an interactive graph (b) where the user is prompted to select the period of steady-state 
evaporation corresponding to evaporation of the fluid layer overlying the sample. Evapore then 
displays threshold value of evaporation rate at which pore draining is considered to begin (c, red 
line), and the user selects the first data point that is continuous with the remainder of the curve. 
Based on the physical properties of the fluid used, temperature, and acquisition interval, Evapore 
computes both an average pore diameter and pore diameter distribution which are rendered to the 
user, with the user prompted to save final result data in .CSV format, compatible with most 
statistical software. 
 
Figure 3: Surface morphology of assessed porous materials 
Evapoporometric pore size data were assessed for (a) Anodisc membranes with a nominal mean 
pore diameter of 100 nm and (b) Amberlyst 15 ion exchange resin beads with nominal mean pore 









Figure 4: Assessment of pore diameter agrees with nominal properties of porous materials 
(a) Evapoporometric mean pore diameters assessed by Evapore correlate strongly (B) with 
nominal reported N2 adsorption pore diameters (slope significantly different from zero, p < 
0.0001), with pore diameter distributions for (c) Anodisc 13 membranes, (d) Amberlyst 15 ion 
exchange resin, and (e) Anodisc 47 membranes.  
 
Figure 5: Estimation of material surface area by evapoporometry 
 
Assessment of material surface area by evapoporometry via the Bachmann-Anderson-Gurvitsch 
rule demonstrated the expected inverse trend of surface area relative to pore diameter, but 
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Volumetric muscle loss overwhelms skeletal muscle’s ordinarily capable regenerative 
machinery, resulting in fibrosis and severe functional deficits which have defied clinical repair 
strategies. In this manuscript we pair the early in vivo functional response to treatment of 
volumetric muscle loss injury using three separate implant strategies to the global transcriptome 
response for each group. We demonstrate that an implant comprising an allogeneic 
decellularized skeletal muscle scaffold seeded with autologous minced muscle expedites 
functional recovery from volumetric muscle loss concurrent with a remarkable increase in 
neuritogenesis and axon guidance transcription in the early period following injury and repair, 
with an unexpected absence of coordinated myogenic transcription. Importantly, these responses 
are observed only when both scaffolding and cellular components are delivered, with the 
combinatorial group recovering 54.7% of the contractile force lost to injury at two weeks post-
injury, compared to -11.8% and 11.3% among groups receiving minced muscle or scaffolding 
only, respectively. The functional recovery and transcriptome profile observed with this 
treatment strategy demonstrate an unexplored yet critical synergy between scaffolding and cells 
during muscle regeneration and invites exploration of the underappreciated role of peripheral 












Skeletal muscle exhibits an innate ability to regenerate small amounts of functional tissue 
following minor traumas including strains and contusions.1 The immediate response to mild 
muscle injury consists of partial necrosis of damaged myofibers and their degradation by 
neutrophils, followed by migration of macrophages to the injury which continue to degrade 
necrotic tissue.2  Hepatocyte growth factor released from injured muscle matrix promotes 
satellite cells residing between myofibers to reenter cell cycle, proliferate, and migrate to sites of 
injury as myoblasts, after which they undergo fusion to form nascent myofibers.3-5 Over the 
course of several days, the community of macrophages present will shift toward a range of 
phenotypes secreting signals promoting myoblast differentiation and connective tissue deposition 
by fibroblasts.6 Alternatively, in the case of volumetric muscle loss (VML), satellite cell 
recruitment and differentiation are overwhelmed by inflammatory signaling and the destruction 
of the basal lamina, leaving fibroblasts as the predominant cell population in the wound during 
the repair and remodeling phase. Consequently, VML injuries result in the formation of non-
contractile scar tissue which prevents the intrusion of nascent myofibers, contributing to a 
permanent deficit in muscle force. 
There exists no consensus on a standard of care for regenerating lost muscle, due to a 
lack of proven therapies and the heterogeneous presentation of VML injuries. Exploratory 
biomaterials for treatment of VML generally attempt to inhibit fibrosis and promote myoblast 
differentiation; typically composed of decellularized skeletal muscle (DSM) or porcine small 
intestinal submucosa, use of these scaffolds in isolation has yielded mixed results.7-11 Particularly 
promising in preclinical study are combinatorial therapies in which precursor cells are combined 




cell delivery method of interest to our group and others16-22 is the use of minced muscle sourced 
from small portions of autologous donor muscle, a clinically translatable source of precursor 
cells.23 Cells from minced muscle (MM) autografts contribute directly to fiber regeneration 
following VML, yet have achieved only modest functional recovery when used in isolation.24 
What is especially intriguing are the functional improvements that can be achieved when a DSM 
matrix and MM autograft are used in combination. Founded on the premise that the matrix 
provides an enabling substrate for regeneration by codelivered cells while minimizing the 
amount of donor tissue required, this implant strategy has recovered half of muscle force lost to 
VML in preclinical models25.  
The breadth of molecular modes by which these combinatorial therapies may coordinate 
force recovery remains unclear, particularly during the early weeks following injury. The lower 
level of recovery occurring in the presence of allogeneic matrix or minced muscle alone 
emphasizes the importance of a multifactorial approach to VML treatment, and suggests a 
biomolecular synergy between these components which to date has not been explored in depth. 
Here we profile the transcriptome-wide responses of VML-injured tissue to scaffolding and cell 
delivery strategies in isolation and combination to better assess early regulatory changes 
potentially mediating differences observed in functional outcome between implant schemes. 
Clarifying the effects of these therapies on the complex inflammatory, fibrotic, and regenerative 
networks in the early period following injury contributes to a foundational understanding of 








Minced muscle-loaded decellularized muscle improves early VML functional outcome 
Ablation of the rat tibialis anterior resulted in defects clearly visible at 3 and 14 days post 
injury (DPI) (Figures 1 and 2). While no clear differences were noted in the gross appearance of 
VML and MM-treated muscles, DSM and DSM+MM implants remained intact in the site of the 
defect, with the DSM+MM appearing better integrated with the muscle than DSM. No 
significant differences in animal growth were observed. Masses of excised TA muscles were 
statistically indistinguishable from excised contralateral uninjured TA across all groups at 3 DPI, 
while the mean mass of VML and MM-treated TA were significantly lower relative to normal at 
14 DPI (78.5% of normal mass with p = 0.0181 and 80.6% of normal mass with p = 0.0351, 
respectively).  
Unrepaired, repaired, and uninjured contralateral limbs were assessed for peak tetanic 
force output at both time points. At 3 DPI, MM and DSM+MM -treated groups exhibited 
significantly lower force output (N/kg body weight) than uninjured contralateral muscles (64.2% 
and 41.6% of uninjured limb force, respectively). Unrepaired, MM, and DSM treatments 
exhibited significantly lower force output (N/kg bw) at 14 DPI relative to uninjured muscles 
(53.6%, 48.2%, and 58.8% of uninjured limb force, respectively) while muscles treated with 
minced muscle loaded onto decellularized muscle matrix (DSM+MM) exhibited a force outcome 








Muscle transcriptomes vary sharply with repair strategy at two weeks post-injury  
Analysis of RNA-seq data in EdgeR revealed a cumulative total of 2686 differentially 
expressed genes (DEGs) across all groups relative to controls (Figure 3). A broadly similar 
pattern of gene expression was observed across all groups at 3 DPI, with the notable exception of 
a marked downregulation of a broad array of macromolecule metabolism genes within the MM 
group (Figure 3B-C). The 3 DPI muscle transcriptomes were otherwise largely dominated by 
upregulation of genes categorized by gene ontology enrichment analysis as related to cell 
migration and regulation of the immune response. 
Gene expression within the unrepaired and MM-repaired groups at 14 DPI demonstrated 
a broad return to baseline levels. The VML14 group exhibited upregulation of 52 genes, 2 of 
which (LIPG and RPLP1) were unique to this group. Of the remaining 50 transcripts, gene 
ontology enrichment identified 22 associated with cell differentiation and 6 related to skeletal 
muscle tissue development. The MM14 group demonstrated upregulation of only 2 transcripts, 
CAV1 and SCD. CAV1 –the only transcript commonly upregulated among all 14 DPI groups- is  
a key constituent of caveolae, a subtype of lipid raft involved in transmembrane signaling26, 
endocytosis27, mechanoprotection across several cell types28, and sarcolemmal organization.29 
SCD encodes the rate-limiting enzyme for the synthesis of monounsaturated fatty acids, is 
associated with fat metabolism and deposition of fat in skeletal muscle30, and is notably the only 
differentially expressed gene upregulated in all groups regardless of time point.31 
While the DSM14 and DSM+MM14 groups demonstrated differential expression of 832 
genes largely related to the acute inflammatory response also differentially expressed by all 3 
DPI groups, 52 DEGs were shared only by DSM14, with 90 DEGs unique to DSM+MM14 




ontology categories comprise 8, 17, and 6 of the 52 DEGs shared by these two groups, 
respectively. Regulation of cell communication, anatomical structure morphogenesis, and 
membrane protein localization comprised the major gene ontology categories overrepresented 
among the 90 DEGs unique to DSM+MM14. The DSM14 and DSM+MM14 groups each 
exhibited remarkable upregulation of transcripts with some role in cell movement annotated by 
IPA, with 424 and 540 cell movement DEGs, respectively. 
Myogenesis and angiogenesis transcription are generally unaffected by VML repair 
Assessment of all groups for the classic markers of precursor cell myogenesis indicate a 
lack of coordinated myogenesis signaling with the exception of an observation of upregulated 
MYF5 and MYOG within the DSM group relative to uninjured controls at 14 DPI (p = 0.004 and 
p = 0.0130, respectively). (Figure 4A-B) Assessment for angiogenesis markers indicate 
nonexpression across all groups for the angiogenic VEGFa and no consistent differential 
expression for associated angiogenic transcripts. (Figure 4C-D) Ingenuity Pathway Analysis 
predicted no significant changes to myogenesis or angiogenesis at the pathway level.  
Profound upregulation of ECM and phagocytosis transcripts persists in DSM and DSM+MM 
repair 
Transcripts for many well-described matrix structural constituents and enzymes, 
including fibrillary collagens, collagen nucleators, and matrix metalloproteinases, were 
consistently found by EdgeR to be profoundly upregulated in both the DSM and DSM+MM 
groups at 14 DPI (Figure 5).  Ingenuity Pathway Analysis identified significant upregulation 
within the hepatic fibrosis canonical pathway for each (p = 1.04E-14 with 39 DEGs and 5.13E-
18 with 49 DEGs, respectively). IPA also identified a general upregulation of transcripts with 




27 with 119 DEGs) groups at this timepoint, respectively. Upregulation of the Fcγ receptor-
mediated phagocytosis pathway was further identified (p = 1.62E-13 with 26 DEGs and p = 
1.83E-13 with 29 DEGs, respectively, Figure 6). Further, the Cell Movement category of 
transcripts was found by Ingenuity Pathway Analysis (IPA) to be significantly upregulated for all 
groups at 3 DPI and the DSM (p = 2.06E-80) and DSM+MM (p = 5.26E-101) groups at 14 DPI. 
Expression of neuritogenesis and axonogenesis associated genes is upregulated in DSM+MM 
repair of VML 
Ingenuity Pathway Analysis identified significant upregulation (p = 2.96E-03) of the 
Neuritogenesis Diseases and Functions annotation within the DSM+MM group at 14 DPI, with 
six genes predicted to be upregulating neuritogenesis. (Figure 7A-B). These include RELN, 
S100B, AHRGEF25, DLG4, GEM, and PMP22, all of which are known to be associated with 
neurite outgrowth.32-37 The DSM-only group also exhibited significant upregulation of 
ARHGEF25, which has also been shown to promote skeletal muscle regeneration in mouse 
tibialis anterior,38 while other groups were insignificant for all neuritogenesis related transcripts 
at the 14 DPI timepoint. Further, Gene ontology enrichment analysis revealed 6 additional genes 
upregulated in both the DSM14 and DSM+MM14 groups related to axonogenesis, including 
ROBO2, BRSK1, MT3, RND2, DCX, and DIXDC1 (Figure 7C-D). In particular the binding of 
ROBO2 receptor with its ligand Slit2 is necessary for the normal bundling of nascent axons 
during muscle innervation.39 When the log2FC threshold for calling differential expression was 
lowered to 1.0, IPA identified substantial changes in the Axonal Guidance Signaling canonical 
pathway in several groups, with 185, 182, 139, and 121 differentially expressed genes in the 3 




axonal guidance signaling were observed only in the DSM and DSM+MM groups, with 78 and 
116 differentially expressed genes, respectively. 
C. Discussion 
In this work we have profiled the global transcriptome expression of the tibialis anterior 
cell community in response to volumetric muscle loss (VML) and subsequent biomaterials-based 
repair strategies. A standard of care for VML remains elusive; implantation of autologous 
minced muscle grafts is capable of promoting some degree of repair but requires prohibitively 
large amounts of donor tissue for extensive VML wounds. An emerging alternative is the use of 
extracellular matrix scaffolds; however, many of those piloted in the literature thus far have 
mixed impacts on functional outcome. Intriguingly, the application of autologous minced muscle 
(MM) pastes to decellularized muscle matrix (DSM) prior to implantation has been shown to 
restore half of the peak contractile force lost to VML (81% of uninjured peak contractile force vs 
62%), while other minced muscle or ECM grafts result in only modest improvement to force 
outcomes.25 Our observation of significant functional recovery (79% of uninjured limb force) in 
groups treated with DSM+MM at 14 days post-injury corroborates this finding and further 
suggests that a substantial fraction of force recovery mediated by this combinatorial repair occurs 
relatively early in the wound-healing process, a novel finding not seen in previous investigations 
potentially due to assessment of recovery at extended time points (8+ weeks post-injury). Our 
data suggest that neither the MM or DSM components in isolation are sufficient to facilitate this 
expeditious force recovery; it is only when combined that they act synergistically to restore force 
in this manner. 
 Intriguingly, confounding the force recovery seen with DSM+MM repair is the 




the recovery observed is unlikely to be mediated by myofiber regeneration alone. Chen and 
Walters have suggested that muscle-derived ECM mediates force recovery in part through the 
provision of a physical bridge through which force can be transmitted across the site of injury.40 
Corona et al further show that relative to untreated VML injuries, implantation of muscle ECM 
biases collagen deposition toward the defect site rather than intramuscular deposition and 
prevents reductions in fiber cross-sectional area, suggesting a protective effect of implanted 
muscle ECM against muscle atrophy following injury.41 Our data indicate that the DSM 
component causes substantial and persistent upregulation of transcripts for the chief fibrillary 
collagens, collagen nucleators42, as well as collagen-degrading matrix metalloproteinases, all 
participants in the remodeling of ECM.43 This combined with the profound upregulation of 
phagocytosis and cell movement related genes illustrates a complex environment within the 
wound in the weeks following VML; while decellularized skeletal muscle has been shown to 
promote myogenesis by acting as a substrate for satellite cell migration and differentiation,44 the 
absence of myogenic signaling, early onset of force recovery within the DSM+MM group, and 
statistically significant force deficit observed for the DSM-only group in this study suggest that 
non-myogenic processes are contributing to VML recovery  in the case of DSM+MM repair.  
 Our observation of substantial upregulation of neuritogenesis and axonogenesis related 
transcripts suggests a possible neurologic involvement in the efficacy of DSM+MM repair of 
VML. Further, when the log2(FC) threshold for calling differential gene expression is lowered 
from 1.5 to 1, IPA detected 116 differentially expressed genes in the DSM+MM14 group within 
the Axon Guidance Signaling canonical pathway. Further, the significant deficits in terminal 
muscle mass, contractile force, and lack of neuroregenerative transcription among unrepaired 




muscle atrophy.45 While most VML investigations in the literature have focused on the influence 
of myofiber atrophy, myogenesis, or immune involvement, Corona et al recently demonstrated 
that VML results in chronic axotomy of ~69% of motoneurons innervating the tibialis anterior, 
concurrent with a large deficit in muscle force.46,47 Crucially, it is shown that while motoneurons 
within the muscle are dramatically affected by VML, this is not accompanied by death of 
associated CNS neurons, suggesting that promoting the innate ability of peripheral nerves to 
regenerate within the muscle may improve the functional outcome of VML. Further,  Given that 
skeletal muscle following denervation is host to a variety of cells including Schwann cells48, it 
may be the case that Schwann cells from the minced muscle graft are better able to participate in 
functional axonogenesis when combined with the DSM substrate which bridges normal muscle 
with the wound. As with normal muscle, the DSM exhibits a longitudinally aligned character; 
several studies suggest that scaffold alignment is a key factor in expediting axonogenesis49-52 
with a recent finding that treatment of VML with a combination of aligned scaffolds and 
rehabilitative exercise increases the formation of mature neuromuscular junctions.53 Further 
study is required to better ascertain whether the aligned character of muscle matrix combined 
with autologous minced muscle may mediate functionally relevant nerve regeneration following 
VML. 
Our observation of prolonged phagocytosis related transcription suggests a significant 
presence of macrophages or other phagocytic cell types at the implant site. While the recruitment 
of macrophages as part of the acute wound response and foreign body response to implants are 
well described, direct participation of these cells in a variety of regenerative processes are 
becoming better appreciated.54,55 Intriguingly, Stratton et al recently demonstrated that 




associated with the injury site resulting in marked reductions in conduction velocity and 
remyelination mediated by the absence of macrophage-derived GAS6.56 Recent research 
suggests that aligned scaffolds contribute to peripheral nerve regeneration by polarizing 
macrophages toward a pro-regenerative phenotype, enhancing the proliferation and migration of 
Schwann cells, again suggesting a potential role for the aligned character of minced muscle 
coated DSM in mediating force recovery in VML.57  
Our data suggest the involvement of several key neuritogenesis, axonogenesis, and axon 
guidance transcripts in VML repair in the early period following injury; interrogation of these 
and other factors influencing nerve regeneration within injured skeletal muscle is relatively 
unexplored, and may yield fruitful targets exploitable by a combination of drug and biomaterials-
based therapies. Studies of global transcriptome expression have revealed that the cellular 
community of skeletal muscle expresses a massive quantity of alternatively spliced transcripts, 
the identities and quantities of which change substantially during the course of myogenesis.58 
The levels of these isoforms are determined largely by the splicing event –not by changes in 
transcription- resulting in these changes being unassessed in standard differential expression 
analyses.59 Clearly, functional analysis of alternatively spliced isoforms expressed in skeletal 
muscle during injury and intervention will develop a fuller understanding of muscle 
pathobiology and repair. It is anticipated that investigations in this area will benefit greatly from 
high sequencing depth and the application of cell sorting technologies for emerging single-cell 
RNA sequencing (scRNA-seq), potentially allowing for the crucial distinction of expression 
between the many cell types present in the muscle during injury and wound-healing. 
 Ultimately, VML injuries exhibit significant heterogeneity. Therefore, a range of clinical 




to best address the complications of this challenging condition. As the expense of RNA-
sequencing technologies decreases and the ease of downstream data analysis increases, whole 
transcriptome expression profiling will be an invaluable tool in guiding the development of 
promising therapies for the treatment of VML.   
D. Methods 
Animals 
26 Sprague Dawley rats (pre-surgical mass ~350 g) were used in this study. 
Buprenorphine (0.1 mL at 0.3 mg/mL) was administered to all rats subcutaneously for 
postoperative analgesia and access to Rimadyl was provided at up to 1 mg per day for seven days 
post-injury. Food and water were provided ad libitum. All animal procedures were approved by 
the Institutional Animal Care and Use Committee of the University of Arkansas.   
Injury and repair  
VML injuries were created in rats using an established VML model.60  Briefly, Lateral 
incisions were made on the lower left legs of Sprague Dawley rats weighing ~350 g, separating 
skin and fascia to expose the TA muscle. An 8 mm biopsy punch was used to remove muscle 
tissue (~100 mg) from the middle third of the TA to a depth of 3 mm. Subsets of rats underwent 
repair of VML injury with autologous minced muscle grafts (MM), SDS/DNase I/RNase A 
decellularized skeletal muscle prepared from rat tibialis anterior (DSM), and a combination of 
DSM and MM (DSM+MM). MM autografts were prepared during surgery by mincing the 
biopsied tissue using microscissors. Fascia and skin were closed using interrupted stiches with 6-






Peak tetanic contractile force of injured and contralateral normal limbs was measured in 
situ at three days and fourteen days post-injury as previously described.25 Briefly, peroneal 
nerves of anesthetized rats were stimulated (150 Hz, 0.1 ms pulse width, 400 ms pulse train) by 
an S88 pulse stimulator (Grass Technologies, West Warwick) to induce contraction of the tibialis 
anterior muscle. Measurement of raw force output (N) was enabled by securing the foot of the 
limb to a force transducer system (Aurora Scientific, Ontario) with surgical tape. Peak tetanic 
force for each limb was calculated by the mean of three contractions and normalized to animal 
mass (N/kg body weight). 
RNA preparation and sequencing 
TA muscles were harvested from euthanized rats at three days and fourteen days post-
injury, snap frozen on liquid nitrogen, and stored at -80°C pending RNA isolation. Tissues were 
thawed and homogenized for 15 s at room temperature. Total RNA was isolated using the 
Purelink RNA Mini Kit (ThermoFisher). RNA concentration was determined by nanodrop 
spectrophotometry, with RNA quality (28S/18s >2, RIN >7) confirmed using a Tapestation 
(Agilent Technologies). cDNA libraries were sequenced on the BGISeq-500 platform to a mean 
depth of 20,000,000 reads per library. 
RNA-seq data analysis 
RNA sequencing reads were mapped to the Rattus norvegicus genome (RGSC build 6.0) 
from USCS using the 2-pass STAR protocol61. Reads were quantified using FeatureCounts62, 
followed by analysis of differential expression and normalization in edgeR63. Differential 
expression was called using a false discovery rate (FDR) cutoff of 0.05 and absolute minimum 
fold change of 1.5. Visualization of group intersections for differential gene expression was 




Biological Process Gene Ontology and KEGG databases in ShinyGO.65 Pathway level analysis 
was also performed using Ingenuity Pathway Analysis (Qiagen)66. 
Statistics 
Statistical analyses for assessment of muscle force were performed using Prism 7 
(Graphpad, La Jolla, California), using repeated measures ANOVA with post-hoc Dunnett’s test. 
Assessment of significance for differential gene expression was performed using EdgeR with 
TMM normalization of read counts and adjustment of p-values for multiple comparisons by the 
Benjamini-Hochberg procedure. Significance was accepted at P ≤ 0.05 (*) P ≤ 0.01 (**), P ≤ 
0.001 (***), and P ≤ 0.0001 (****). Quantitative data are displayed as mean + standard 
deviation.  
Data availability 
All RNA-sequencing files were deposited in the Gene Expression Omnibus 
(https://www.ncbi.nlm.nih.gov/geo/) under accession number GSE125896. All other data 
supporting the findings of this study are available from the authors upon reasonable request. 
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Figure 1: Creation of VML injuries and subsequent repair strategies. 
 
Rat tibialis anterior muscles were subjected to VML following implant repair strategies including 
minced muscle (MM), decellularized skeletal muscle (DSM), and a combination of the two 
(DSM+MM). 
 
Figure 2: Codelivery of decellularized skeletal muscle with minced muscle preserves muscle 
contractile force.  
(Top) Gross appearance of tibialis anterior muscles for groups at three and fourteen days post 
injury (DPI). (a and b) Tibialis anterior mass (g/kg rat body weight) at three and fourteen DPI, 
respectively. Electrophysiological measurement of mean peak contractile force of the tibialis 
anterior for all groups at (c) three and (d) fourteen DPI, respectively, indicating deficits in 
functional outcome among VML, MM, and DSM-treated muscles relative to the uninjured 
contralateral limb at 14 DPI (p <0.0001, <0.0001, and 0.0003, respectively). DSM+MM 
exhibited a significant deficit in force at 3 DPI but not 14 DPI. Error bars are presented as ± 
standard deviation. 
 
Figure 3: Global transcription within the VML cell community diverges profoundly based 
on repair strategy.  
(a) Heatmap of log2FC for all differentially expressed genes (DEGs) across all groups, with 
hierarchical clustering of gene expression data visualized using one minus Pearson correlation 
with average linkage. (b) Visualization of the top 15 DEG intersections across groups was 
performed using UpsetR, with (c) significantly overrepresented gene sets for the top 3 
intersections assessed by querying the Gene Ontology Biological Process database. 
 
Figure 4: Myogenesis and angiogenesis transcription are insensitive to VML repair.  
 
(a) Heatmap of Log2FC with (b) mean ± standard deviation plots of normalized expression 
counts for transcript-level markers of myogenesis and (c) heatmap of Log2FC and (d) mean ± 










Figure 5: Highly upregulated extracellular matrix constituent transcription persists in  
 
DSM and DSM+MM repair. 
 
(a) Heatmap of Log2FC and (b) mean ± standard deviation plots of normalized expression counts 
for extracellular matrix transcripts. 
 
Figure 6: Highly upregulated phagocytosis associated transcription persists in DSM and  
 
DSM+MM repair.  
 
(a) Heatmap of Log2FC and (b) mean ± standard deviation plots of normalized expression counts 
for phagocytosis related transcripts. 
 




(a) Heatmap of Log2FC with  (b) mean ± standard deviation plots of normalized  
expression counts for transcript-level markers of neuritogenesis and (c) heatmap of Log2FC with 























































































































 Despite significant advances in the past decade in the engineering of therapeutic 
biomaterials at the lab scale, little change has occurred in the fundamental clinical practice of 
treating VML.  The ~22 human subjects evaluated across 4 VML clinical reports1-4 of ECM-
based therapies exhibit substantial variation in degree and site of injury which makes rigorous 
assessment of implant efficacy difficult. Additionally, the differing methods for assessing 
functional outcome between clinical studies and the broad preclinical VML literature suggest a 
need for future animal studies to add additional clinically relevant measures of functional 
recovery such as measures of range of motion. While electrophysiological stimulation provides a 
precise absolute measure of force recovery, this is generally replaced in humans subjects with the 
application of dynamometers, and the lack of biomechanical data in animals beyond raw force 
makes comparison to clinical reports difficult; application of a standardized noninvasive 
electrophysiological stimulation approach5 between preclinical and clinical studies of VML may 
improve confidence in the clinical relevance of preclinical force data. Overall, a more controlled 
approach to clinical evaluation of VML therapies is necessary for translation of promising lab-
scale therapies to the clinic. In particular, an opt-in HIPAA-compliant registry of clinical data 
from VML subjects -similar to those used for subject recruitment in cancer and diabetes 
research6- would enable improved communication between researchers and clinicians for 
mobilizing appropriate subjects for controlled trials. 
 A significant challenge in treating VML is that musculoskeletal clinicians are most likely 
to encounter patients long after their initial injury, when the site of the wound has already 




magnitude of fibrosis in massive musculoskeletal trauma can be greater than that in the 
degenerative fibrosis of other tissues, recent findings suggesting the ability of specific 
compounds to revert fibrosis in the heart7, liver8, and other tissues9 may be of use to the filed. 
Most VML preclinical studies have understandably focused on the idealized scenario of 
immediate repair of injury; given that this ideal is not reflected in the clinic, assessing the ability 
of biomaterials to promote functional regeneration long after the initial injury would provide 
clinically relevant insight. A transcriptomic study of VML in male rats was presented in chapter 
5 suggesting that muscle force may be preserved in DSM+MM treatment of muscle, that 
promotion of neuroregenerative signaling may play a role in mediating this preservation, and that 
this preservation can be brought about in the two weeks following injury. Therefore, despite the 
(typically) months of time between the initial VML injury and onset of recuperative therapies, 
beginning therapeutic interventions immediately after injury may be critical to outcome. As the 
biological understanding of the skeletal muscle cell community in VML improves, it is evident 
that key biochemical information informing the design of therapeutic biomaterials will be more 
readily available. Specifically, elucidating key molecular mechanisms mediating skeletal muscle 
regeneration, inflammation, fibrosis, and innervation will provide tangible molecular targets 
which materials can be engineered to affect, by inclusion of exogenous molecules that act on 
specific pathways or by the codelivery of purposely-conditioned cells.  
VML researchers have evaluated the effects of biological scaffolds and some myogenic 
precursor cell delivery on functional outcome, but this has generally occurred with little 
deliberate engineering of materials and cells for the microenvironment of skeletal muscle; 
certainly the cellular heterogeneity of any injured tissue complicates the usefulness of omics data 




already providing a wealth of remarkably informative data for the regeneration of various tissues 
that is currently missing in VML.10-14 Of the three investigations applying RNA-sequencing to 
VML injury and repair15,16 -including that of this author described in chapter 5- none isolate the 
global transcriptomic response of specific cell types in VML. Additionally, missing from the 
VML research community is the application of other next-generation technologies such as 
quantitative mass spectrometry proteomics.17 Integration of data from transcriptomic and 
proteomic methods is currently providing to other areas of biology18-21 a more comprehensive 
screening of relevant cell behavior than classic methods (qPCR, western blot, etc.), and it is the 
opinion of this author that the collective understanding of VML pathobiology and repair will 
benefit greatly from their application. Further, the continually decreasing financial cost of these 
techniques is anticipated to lead to their application in personalized medicine22, and the strategic 
decision to apply omics technologies to VML research now will provide datasets that would 
doubtlessly inform the development of future therapies.  
Polymorphisms of individuals impairing peripheral nerve regeneration, myogenesis, and 
the inflammatory-to-constructive myeloid cell transition are key examples of personalized 
treatment targets assessable by next generation techniques. While sex differences in the outcome 
of VML-specific therapies have not been targeted for study thus far, the 2016 implementation of 
the Sex as a Biological Variable (SABV) policy by the NIH is expected to ameliorate this 
shortcoming. Interestingly, limited study demonstrates that female muscle-derived stem cells 
exhibit a capacity for regeneration greater than their male counterparts23, with the mechanism 
responsible remaining unclear. Thus, not only may outcome vary between the sexes, but the 
expectation that female donor cells outperform those of males also necessitates that future 




 In addition to adopting more high throughput methods for analyzing transcriptomic and 
proteomic changes relevant to VML and potential interventions, a redoubled exploration of 
musculoskeletal molecular biology may be clinically useful; in particular, study of epigenetic 
changes such as DNA methylation at cytosine-guanine (CpG) dinucleotides, histone 
modification, and noncoding RNA expression may play roles in muscle injury and regeneration. 
Epigenetic modifications are both reversible and can cause pathologically relevant changes in 
gene expression, with several inhibitors of histone deacetylation and DNA methylation having 
been FDA-approved and clinically applied.24 Notably, evidence suggests that DNA methylation 
is in activating the expression of several genes during the commitment of cells to a myogenic 
lineage.25 For example, the activation of the myogenic gene program following satellite cell 
activation is now known to be mediated by decreases in NAD+ and a consequent decrease in the 
deacetylase SIRT1, allowing for increased acetylation of lysine 16 of histone 426, a particularly 
important site whose acetylation leads to conversion of heterochromatin to euchromatin, making 
sites throughout the genome more accessible for transcription.27 DNA methylation itself is 
known to increase substantially during aging with such predictability that one group developed a 
DNA methylation model which predicts age from DNA methylation profile with a correlation of 
96% and error of approximately 3 years.28 Sarcopenia29 and reduced satellite cell content30 are 
observed in the elderly, with SPRY1 being one site of age-associated DNA methylation resulting 
in reduction of the available pool of quiescent satellite cells.31 Interestingly, acute exercise has 
been shown to reduce methylation of genomic sites associated with skeletal muscle metabolism, 
suggesting a role for methylation in the effects of physical therapy in the elderly and a specific 
mechanism by which increased activity may minimize the deleterious effects of aging on skeletal 




DNA methylation34 and its application in combination with transcriptomic and proteomic 
techniques will provide an additional layer of biological insight for VML treatment.  
 Noncoding RNAs (ncRNAs) are RNA molecules which have independent functions and 
do not generally undergo translation into peptides, with many functioning to regulate gene 
expression across the transcriptome.35 A number of ncRNAs have been shown to govern satellite 
cell proliferation and differentiation.36-38 Circular RNAs (circRNAs) are a relatively unexplored 
class of RNA molecules which are relatively stable compared to their linear counterparts, with 
some demonstrated potential to bind microRNA molecules.39 NcRNAs -including circRNAs- are 
in some cases enriched in exosomes40,41, including those of muscle-resident cells, with the 
potential to directly affect the muscle fibrosis and regeneration.42,43 Recent direct evidence of 
cell-to-cell contacts and exosome exchange between macrophages and satellite cells from 
activation through myoblast fusion suggests a direct intracellular crosstalk which could be 
mediated in part by the exchange of noncoding RNAs; elucidating the identities and functions of 
relevant noncoding RNAs in skeletal muscle and their responses to injury and biomaterial 
therapies should therefore be yet another goal in bettering the collective understanding of VML 
pathobiology. 
 Remarkable insights have recently been made in the understanding of vertebrate limb 
regeneration observed in Urodela amphibians which are relevant to muscle regeneration. While 
humans have homologs for many of the same key limb regeneration associated genes as 
Urodela, in practice these are not typically expressed following injury. Limb-regenerating 
vertebrates mobilize the dedifferentiation of injury-adjacent cells to form a blastema, from which 
these cells can redifferentiate to reform the complete range of tissues in a limb.44 Interestingly, 




their tissue origin and remain committed to a tissue-specific lineage. For example, 
dedifferentiated skeletal muscle cells contribute to reformation of skeletal muscle in a limb but 
do not contribute to cartilage formation.45 Recapitulating this process in humans is considered to 
be eventually feasible, but recent estimates of treatment time indicate that the time course for 
complete regeneration of a whole limb from a functioning blastema would likely range from 2-5 
years, with complex pharmacological cues to guide morphogenesis throughout treatment.46 
Forming a functional blastema in humans is an awesome interdisciplinary challenge which will 
require extensive series of studies mapping the process as it exists in current models and 
engineering human cells to mimic it. A complete genome sequence for the critical regenerative 
model Ambystoma mexicanum was only recently published in 201847 with a  chromosome-scale 
assembly of the massive 32 Gb genome released in early 2019.48 A complete definition of the 
molecular mechanisms mediating blastema formation in both amphibian models and mammalian 
digit tip regeneration will be a necessary step toward limb regeneration.49 Despite the enormous 
technical challenges involved, limb regeneration in amphibians is the only extensively 
characterized example of complete vertebrate muscle regeneration following VML, and so 
engineering this process in human cells -which retain much of the necessary machinery 
involved- might be the most fruitful approach for achieving complete functional regeneration 
over the long term. 
 Autologous muscle transfer is occasionally performed as a treatment for muscle loss, but 
clearly results in morbidity at the donor site (typically the latissimus dorsi first used for head and 
neck reconstruction in 197850 or the gracilis51-54) and can require a prohibitively large volume of 
tissue in the case of VML.55 Thus, there is interest in the in vitro production of tissue-like 




provides finer control over implant composition and architecture, scale-up of methods for the 
bulk production of ECM will be needed to generate a clinically useful amount of tissue. A 
number of bioreactor schemes are available that could be applied for this purpose, including 
existing hollow fiber membrane bioreactors with the potential to leverage the productivity of cell 
densities as high as 1010 cells per membrane cartridge.56  The rapid proliferation of mammalian 
cells in dynamic bioreactors additionally provides the opportunity for expansion of a patients’ 
own precursor cells and, thereby, production of an autologous ECM minimizing foreign epitopes 
and their inflammatory consequences. A new approach for producing ECM in vitro was 
described in chapters 2 and 3 whereby asymmetric hollow fiber membranes are used as a 
sacrificial cell culture substrate for mammalian cells, with ECM isolated through the dissolution 
of the membrane by an appropriate solvent as continuous threads of whole matrix. While the 
effectiveness of implants derived from these threads in the treatment of VML is the subject of an 
ongoing preclinical study, several avenues exist to improve upon this first generation of 
sacrificial culture-derived ECM. The current platform is based on the static culture of fibroblasts 
on hollow fibers, and therefore does not leverage the aforementioned benefits of dynamic 
bioreactor culture with commercial membrane cartridges; evaluating sacrificial hollow fiber cell 
culture at a pilot scale will better reveal the feasibility of this approach for satisfying a 
commercial demand for ECM. A recognized concern in the approach is the use of irritating 
solvents such as N-methyl-2-pyrrolidone (NMP) in the isolation of ECM from the sacrificial 
membranes. While overall proteinaceous composition and retention of ECM constituents within 
the resulting scaffolds is demonstrated in chapter 2, the potential effects of such solvents on 
scaffold composition have not been extensively evaluated, and so the process may benefit from 




upon the development of thermally responsive polymers such as PNIPAAM which can be 
dissociated from cells and ECM by a modest change in temperature. Conveniently, processes for 
preparing PNIPAAM-grafted hollow fibers are described in the literature57-59 and have even been 
successfully exploited for isolation of adhered mammalian cells through the thermal dissociation 
mechanism.59 Hu et al also developed a spinning process for producing wholly NIPAAM hollow 
fibers which could allow for streamlining the fabrication and cell culture processes into a single 
simultaneous step.60  
 In summary, VML is a challenging pathology which will require the coordinated 
interdisciplinary efforts of biologists, tissue engineers, materials scientists, and clinicians to 
address adequately. Clearly, much remains to be learned in terms of the molecular processes 
governing the homeostasis of normal skeletal muscle, let alone the processes relevant to recovery 
of muscle from severe trauma. However, new technologies now allow for their characterization 
at the genomic, epigenomic, transcriptomic, and proteomic scales which are expected to reveal 
clinically useful targets. Some biomaterial and cell delivery therapies for VML have been 
developed at the lab scale -including the DSM+MM approach- and have shown promising results 
at the preclinical stage. As the DSM component of this specific approach would likely require 
FDA regulatory approval, it may be prudent to begin assessing the approach across multiple 
animal models in anticipation of the regulatory process. Alternatively, clinical application of 
MM itself would not require regulatory approval. Regardless of the specific promising 
approaches that are translated, the differing methods for assessing functional outcomes 
(dynamometers, electrostimulation, etc.) in the preclinical and clinical settings should be unified 
to enhance the predictive value of VML animal studies on clinical outcome. In the longer term, 




production of ECM with more control over implant architecture and composition than is allowed 
with the simple decellularization of cadaveric tissues, with the possibility of proliferating a 
patients’ own cells, enabling the engineering of personalized ECM implants. Further yet, the 
recent insights into limb regeneration in amphibian models and the conservation of relevant 
genes across vertebrates hold the distant promise of leveraging the latent regenerative potential 
of dedifferentiated cells, gene therapies, and pharmacological treatments for complete 
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Figure 1: Graft Alignment Correlates With Degree of Intramuscular Collagen 
Deposition 
Collagen I (green) and MHC (red) composite immunofluorescence imaging for (A) uninjured, 
(B) 0°, (C) 45°, and (D) 90° alignment groups at 12 weeks post injury, with (E) image analysis 
for noncontractile tissue area as a percent of total thresholded area. Scale-bar = 100 µm. 
 
Figure 2: Transcriptome Profiling of Graft Alignment 
(A) Heatmap of log2FC for all differentially expressed genes (104 unique DEGs) across all 0° 
and 90° groups relative to uninjured contralateral limbs at 2 weeks post-injury. (B) 
Visualization of the top DEG intersections across all groups with (C) the top canonical 
pathways for each group identified by Ingenuity Pathway Analysis.   
 
Figure 3: Autologous Graft Excision and Reinsertion 
(A) Graphical schematic of graft excision and reinsertion, with gross imaging of (B) biopsy, 
(C) defect creation, (D) graft alignment, and (E) graft reinsertion. 
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